DE3013930A1 - 2-Per:hydro:diazine-pyrimido-pyrimidine derivs. - with antithrombotic activity, used e.g for prophylaxis of thromboembolic and arteriosclerosis - Google Patents
2-Per:hydro:diazine-pyrimido-pyrimidine derivs. - with antithrombotic activity, used e.g for prophylaxis of thromboembolic and arteriosclerosisInfo
- Publication number
- DE3013930A1 DE3013930A1 DE19803013930 DE3013930A DE3013930A1 DE 3013930 A1 DE3013930 A1 DE 3013930A1 DE 19803013930 DE19803013930 DE 19803013930 DE 3013930 A DE3013930 A DE 3013930A DE 3013930 A1 DE3013930 A1 DE 3013930A1
- Authority
- DE
- Germany
- Prior art keywords
- group
- thiomorpholino
- pyrimido
- pyrimidine
- melting point
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000011321 prophylaxis Methods 0.000 title claims description 5
- 206010003210 Arteriosclerosis Diseases 0.000 title claims description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 title claims description 3
- 230000002785 anti-thrombosis Effects 0.000 title description 3
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 title 1
- 230000009424 thromboembolic effect Effects 0.000 title 1
- -1 methylenedioxy- benzyl Chemical group 0.000 claims abstract description 171
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 30
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 22
- 239000002253 acid Substances 0.000 claims abstract description 21
- 150000003839 salts Chemical class 0.000 claims abstract description 16
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims abstract description 14
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 12
- 125000005505 thiomorpholino group Chemical group 0.000 claims abstract description 12
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 11
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 9
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims abstract description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 4
- 125000004076 pyridyl group Chemical group 0.000 claims abstract description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 120
- 150000001875 compounds Chemical class 0.000 claims description 39
- 125000004432 carbon atom Chemical group C* 0.000 claims description 35
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 11
- 125000002252 acyl group Chemical group 0.000 claims description 9
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 8
- 239000011737 fluorine Substances 0.000 claims description 8
- 150000007524 organic acids Chemical class 0.000 claims description 8
- 230000003647 oxidation Effects 0.000 claims description 8
- 238000007254 oxidation reaction Methods 0.000 claims description 8
- 230000001681 protective effect Effects 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- 150000007522 mineralic acids Chemical class 0.000 claims description 7
- 235000005985 organic acids Nutrition 0.000 claims description 7
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 6
- 238000003776 cleavage reaction Methods 0.000 claims description 6
- VHUDRBVSGPPPMR-UHFFFAOYSA-N n-benzyl-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CS(=O)CCN1C(C1=NC=N2)=NC(N3CCNCC3)=NC1=C2NCC1=CC=CC=C1 VHUDRBVSGPPPMR-UHFFFAOYSA-N 0.000 claims description 6
- 230000000269 nucleophilic effect Effects 0.000 claims description 6
- 230000007017 scission Effects 0.000 claims description 6
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 5
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- 125000003282 alkyl amino group Chemical group 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 4
- 230000010933 acylation Effects 0.000 claims description 3
- 238000005917 acylation reaction Methods 0.000 claims description 3
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- 125000002425 furfuryl group Chemical group C(C1=CC=CO1)* 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 150000007530 organic bases Chemical group 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 206010027476 Metastases Diseases 0.000 claims description 2
- 208000001435 Thromboembolism Diseases 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 125000001246 bromo group Chemical group Br* 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- LISQGJSNQRUWSI-UHFFFAOYSA-N n-benzyl-2-piperazin-1-yl-4-thiomorpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=1C=CC=CC=1CNC(C1=N2)=NC=NC1=C(N1CCSCC1)N=C2N1CCNCC1 LISQGJSNQRUWSI-UHFFFAOYSA-N 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract description 2
- 229910052794 bromium Inorganic materials 0.000 abstract description 2
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 abstract description 2
- JOZPEVMCAKXSEY-UHFFFAOYSA-N pyrimido[5,4-d]pyrimidine Chemical compound N1=CN=CC2=NC=NC=C21 JOZPEVMCAKXSEY-UHFFFAOYSA-N 0.000 abstract description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 abstract 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 abstract 1
- 238000002844 melting Methods 0.000 description 205
- 230000008018 melting Effects 0.000 description 204
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 57
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 229960000583 acetic acid Drugs 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000155 melt Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- MSSDTZLYNMFTKN-UHFFFAOYSA-N 1-Piperazinecarboxaldehyde Chemical compound O=CN1CCNCC1 MSSDTZLYNMFTKN-UHFFFAOYSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 239000008298 dragée Substances 0.000 description 5
- 239000012362 glacial acetic acid Substances 0.000 description 5
- IYHKZYBVJJPGFD-UHFFFAOYSA-N n-benzyl-2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 IYHKZYBVJJPGFD-UHFFFAOYSA-N 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000829 suppository Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- JNKWPASLLGLIDK-UHFFFAOYSA-N 2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)-n-(2-phenylethyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 JNKWPASLLGLIDK-UHFFFAOYSA-N 0.000 description 3
- HJBHJSQWKRDWNG-UHFFFAOYSA-N 2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C(Cl)N=C2C(N)=NC=NC2=C1N1CCS(=O)CC1 HJBHJSQWKRDWNG-UHFFFAOYSA-N 0.000 description 3
- NDBOINBDQJKCKI-UHFFFAOYSA-N 4-(2-chloro-8-morpholin-4-ylpyrimido[5,4-d]pyrimidin-4-yl)-1,4-thiazinane 1-oxide Chemical compound C=12N=CN=C(N3CCOCC3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 NDBOINBDQJKCKI-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- NKZIUOBNMSSKNT-UHFFFAOYSA-N n-[(3,4-dichlorophenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C12 NKZIUOBNMSSKNT-UHFFFAOYSA-N 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- ACDGUFIAHFBWEP-UHFFFAOYSA-N 2-[[2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-yl]amino]ethanol Chemical compound N1=C(Cl)N=C2C(NCCO)=NC=NC2=C1N1CCS(=O)CC1 ACDGUFIAHFBWEP-UHFFFAOYSA-N 0.000 description 2
- OBUJUPGRRMYOOL-UHFFFAOYSA-N 2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)-n-(pyridin-3-ylmethyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3C=NC=CC=3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 OBUJUPGRRMYOOL-UHFFFAOYSA-N 0.000 description 2
- OTZDLRDMDIDARJ-UHFFFAOYSA-N 2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)-n-phenylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 OTZDLRDMDIDARJ-UHFFFAOYSA-N 0.000 description 2
- SKRDSSPYXAQLBL-UHFFFAOYSA-N 2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)-n-propan-2-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C(Cl)N=C2C(NC(C)C)=NC=NC2=C1N1CCS(=O)CC1 SKRDSSPYXAQLBL-UHFFFAOYSA-N 0.000 description 2
- ZSEAGDSPEIYWOP-UHFFFAOYSA-N 2-chloro-4-morpholin-4-yl-n-(2-phenylethyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCOCC1 ZSEAGDSPEIYWOP-UHFFFAOYSA-N 0.000 description 2
- ZFYOYYDCPNRHBL-UHFFFAOYSA-N 2-chloro-n,n-diethyl-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C(Cl)N=C2C(N(CC)CC)=NC=NC2=C1N1CCS(=O)CC1 ZFYOYYDCPNRHBL-UHFFFAOYSA-N 0.000 description 2
- PWQYDCNJMAJUNP-UHFFFAOYSA-N 2-chloro-n-(4-ethoxyphenyl)-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(OCC)=CC=C1NC1=NC=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C12 PWQYDCNJMAJUNP-UHFFFAOYSA-N 0.000 description 2
- ZJWHDDLDLBALFN-UHFFFAOYSA-N 2-chloro-n-(furan-2-ylmethyl)-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3OC=CC=3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 ZJWHDDLDLBALFN-UHFFFAOYSA-N 0.000 description 2
- JGBJNDBELMESBL-UHFFFAOYSA-N 2-chloro-n-[(3,4-dichlorophenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3C=C(Cl)C(Cl)=CC=3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 JGBJNDBELMESBL-UHFFFAOYSA-N 0.000 description 2
- OIEYIHVDLLUVGL-UHFFFAOYSA-N 2-chloro-n-[(3,4-dimethoxyphenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C12 OIEYIHVDLLUVGL-UHFFFAOYSA-N 0.000 description 2
- ADDYRJLHTMDCJU-UHFFFAOYSA-N 2-chloro-n-[(4-methylphenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(C)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C12 ADDYRJLHTMDCJU-UHFFFAOYSA-N 0.000 description 2
- WVWJKNQXRYOAGW-UHFFFAOYSA-N 2-chloro-n-[2-(3,4-dimethoxyphenyl)ethyl]-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C12 WVWJKNQXRYOAGW-UHFFFAOYSA-N 0.000 description 2
- CWACFUMTKWWHLX-UHFFFAOYSA-N 2-chloro-n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C(Cl)N=C2C(NC)=NC=NC2=C1N1CCS(=O)CC1 CWACFUMTKWWHLX-UHFFFAOYSA-N 0.000 description 2
- LPYXEMXXVOAEAR-UHFFFAOYSA-N 2-chloro-n-methyl-4-morpholin-4-yl-n-phenylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCOCC3)N=C(Cl)N=C2C=1N(C)C1=CC=CC=C1 LPYXEMXXVOAEAR-UHFFFAOYSA-N 0.000 description 2
- LCDAMJHOMGJDHA-UHFFFAOYSA-N 4-(2-chloro-8-thiomorpholin-4-ylpyrimido[5,4-d]pyrimidin-4-yl)-1,4-thiazinane 1-oxide Chemical compound C=12N=CN=C(N3CCSCC3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 LCDAMJHOMGJDHA-UHFFFAOYSA-N 0.000 description 2
- OSWBOPXDSXQOFG-UHFFFAOYSA-N 4-pyrimido[5,4-d]pyrimidin-2-yl-1,4-thiazinane 1-oxide Chemical compound C1CS(=O)CCN1C1=NC=C(N=CN=C2)C2=N1 OSWBOPXDSXQOFG-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 150000004651 carbonic acid esters Chemical group 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940116364 hard fat Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- WTOVLVLZANHWRE-UHFFFAOYSA-N n-benzyl-2-chloro-n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C2C=1N(C)CC1=CC=CC=C1 WTOVLVLZANHWRE-UHFFFAOYSA-N 0.000 description 2
- XQZMYQNZMUBCRQ-UHFFFAOYSA-N n-benzyl-n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C2C=1N(C)CC1=CC=CC=C1 XQZMYQNZMUBCRQ-UHFFFAOYSA-N 0.000 description 2
- QGHAKRLNFIGKRC-UHFFFAOYSA-N n-butyl-2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C(Cl)N=C2C(NCCCC)=NC=NC2=C1N1CCS(=O)CC1 QGHAKRLNFIGKRC-UHFFFAOYSA-N 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- WTGVJERCTXWBLZ-WLHGVMLRSA-N (e)-but-2-enedioic acid;2-hydroxybenzoic acid Chemical compound OC(=O)\C=C\C(O)=O.OC(=O)C1=CC=CC=C1O WTGVJERCTXWBLZ-WLHGVMLRSA-N 0.000 description 1
- YHIIJNLSGULWAA-UHFFFAOYSA-N 1,4-thiazinane 1-oxide Chemical compound O=S1CCNCC1 YHIIJNLSGULWAA-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- XYPISWUKQGWYGX-UHFFFAOYSA-N 2,2,2-trifluoroethaneperoxoic acid Chemical compound OOC(=O)C(F)(F)F XYPISWUKQGWYGX-UHFFFAOYSA-N 0.000 description 1
- NAFUNWHDBUAYDX-UHFFFAOYSA-N 2-[4-[4-(1-oxo-1,4-thiazinan-4-yl)-8-(2-phenylethylamino)pyrimido[5,4-d]pyrimidin-2-yl]piperazin-1-yl]ethanol Chemical compound C1CN(CCO)CCN1C1=NC(N2CCS(=O)CC2)=C(N=CN=C2NCCC=3C=CC=CC=3)C2=N1 NAFUNWHDBUAYDX-UHFFFAOYSA-N 0.000 description 1
- IORYHECVUDYXAM-UHFFFAOYSA-N 2-[4-[8-(benzylamino)-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-2-yl]piperazin-1-yl]ethanol Chemical compound C1CN(CCO)CCN1C1=NC(N2CCOCC2)=C(N=CN=C2NCC=3C=CC=CC=3)C2=N1 IORYHECVUDYXAM-UHFFFAOYSA-N 0.000 description 1
- ZGDLOWMGNPQOCO-UHFFFAOYSA-N 2-[4-[8-[benzyl(methyl)amino]-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-2-yl]piperazin-1-yl]ethanol Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(N3CCN(CCO)CC3)N=C2C=1N(C)CC1=CC=CC=C1 ZGDLOWMGNPQOCO-UHFFFAOYSA-N 0.000 description 1
- DYMXVBBIUGISSN-UHFFFAOYSA-N 2-[benzyl-[2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-yl]amino]ethanol Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C2C=1N(CCO)CC1=CC=CC=C1 DYMXVBBIUGISSN-UHFFFAOYSA-N 0.000 description 1
- AXZMQJCDVKJBIM-UHFFFAOYSA-N 2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)-n-(3-phenylpropyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCCCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 AXZMQJCDVKJBIM-UHFFFAOYSA-N 0.000 description 1
- HXOKPKUMLAJKBM-UHFFFAOYSA-N 2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)-n-[3-(trifluoromethyl)phenyl]pyrimido[5,4-d]pyrimidin-8-amine Chemical compound FC(F)(F)C1=CC=CC(NC=2C3=NC(Cl)=NC(=C3N=CN=2)N2CCS(=O)CC2)=C1 HXOKPKUMLAJKBM-UHFFFAOYSA-N 0.000 description 1
- CGPQROHBTBWGQR-UHFFFAOYSA-N 2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)-n-propylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C(Cl)N=C2C(NCCC)=NC=NC2=C1N1CCS(=O)CC1 CGPQROHBTBWGQR-UHFFFAOYSA-N 0.000 description 1
- WIGPMPALWYJREF-UHFFFAOYSA-N 2-chloro-4-morpholin-4-yl-n-phenylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCOCC1 WIGPMPALWYJREF-UHFFFAOYSA-N 0.000 description 1
- PODDVMFKNLFUIX-UHFFFAOYSA-N 2-chloro-n-(3-methylbutyl)-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C(Cl)N=C2C(NCCC(C)C)=NC=NC2=C1N1CCS(=O)CC1 PODDVMFKNLFUIX-UHFFFAOYSA-N 0.000 description 1
- ZMYUTNZOLFMWHO-UHFFFAOYSA-N 2-chloro-n-[(2,4-dichlorophenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound ClC1=CC(Cl)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C12 ZMYUTNZOLFMWHO-UHFFFAOYSA-N 0.000 description 1
- YTEIUUCTXQTNMS-UHFFFAOYSA-N 2-chloro-n-[(2-chlorophenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3C(=CC=CC=3)Cl)C2=NC(Cl)=NC=1N1CCS(=O)CC1 YTEIUUCTXQTNMS-UHFFFAOYSA-N 0.000 description 1
- VDRKOQGHLJVZNN-UHFFFAOYSA-N 2-chloro-n-[(3-chlorophenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound ClC1=CC=CC(CNC=2C3=NC(Cl)=NC(=C3N=CN=2)N2CCS(=O)CC2)=C1 VDRKOQGHLJVZNN-UHFFFAOYSA-N 0.000 description 1
- JKVREDDAQPKVTC-UHFFFAOYSA-N 2-chloro-n-[(4-fluorophenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(F)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C12 JKVREDDAQPKVTC-UHFFFAOYSA-N 0.000 description 1
- RTJKYKMOPHIKIB-UHFFFAOYSA-N 2-chloro-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C1=NC=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C12 RTJKYKMOPHIKIB-UHFFFAOYSA-N 0.000 description 1
- DZMYVHLRLLFHTK-UHFFFAOYSA-N 2-chloro-n-cyclohexyl-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NC3CCCCC3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 DZMYVHLRLLFHTK-UHFFFAOYSA-N 0.000 description 1
- YAFZJYOZAWUODE-UHFFFAOYSA-N 2-chloro-n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)-n-(pyridin-3-ylmethyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C2C=1N(C)CC1=CC=CN=C1 YAFZJYOZAWUODE-UHFFFAOYSA-N 0.000 description 1
- VJHHSMCEFDQFKW-UHFFFAOYSA-N 2-chloro-n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)-n-phenylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C2C=1N(C)C1=CC=CC=C1 VJHHSMCEFDQFKW-UHFFFAOYSA-N 0.000 description 1
- SVJWTQHVIIKANM-UHFFFAOYSA-N 2-chloro-n-octyl-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C(Cl)N=C2C(NCCCCCCCC)=NC=NC2=C1N1CCS(=O)CC1 SVJWTQHVIIKANM-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- CTTCROPCNJWYML-UHFFFAOYSA-N 4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-yl-n-(pyridin-3-ylmethyl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CS(=O)CCN1C(C1=NC=N2)=NC(N3CCNCC3)=NC1=C2NCC1=CC=CN=C1 CTTCROPCNJWYML-UHFFFAOYSA-N 0.000 description 1
- CILKGFYHRRNOTQ-UHFFFAOYSA-N 4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-yl-n-[3-(trifluoromethyl)phenyl]pyrimido[5,4-d]pyrimidin-8-amine Chemical compound FC(F)(F)C1=CC=CC(NC=2C3=NC(=NC(=C3N=CN=2)N2CCS(=O)CC2)N2CCNCC2)=C1 CILKGFYHRRNOTQ-UHFFFAOYSA-N 0.000 description 1
- LHBIZCQQXFDOHF-UHFFFAOYSA-N 4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-yl-n-propan-2-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C2C(NC(C)C)=NC=NC2=C(N2CCS(=O)CC2)N=C1N1CCNCC1 LHBIZCQQXFDOHF-UHFFFAOYSA-N 0.000 description 1
- UCKCTWGJPFGJCY-UHFFFAOYSA-N 4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-yl-n-propylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C2C(NCCC)=NC=NC2=C(N2CCS(=O)CC2)N=C1N1CCNCC1 UCKCTWGJPFGJCY-UHFFFAOYSA-N 0.000 description 1
- HFWFROWYIDYMDW-UHFFFAOYSA-N 4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C2C(N)=NC=NC2=C(N2CCS(=O)CC2)N=C1N1CCNCC1 HFWFROWYIDYMDW-UHFFFAOYSA-N 0.000 description 1
- ZTKCNBHRUJTBHY-UHFFFAOYSA-N 4-(1-oxo-1,4-thiazinan-4-yl)-n-(3-phenylpropyl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CS(=O)CCN1C(C1=NC=N2)=NC(N3CCNCC3)=NC1=C2NCCCC1=CC=CC=C1 ZTKCNBHRUJTBHY-UHFFFAOYSA-N 0.000 description 1
- APLDGUGEEOJUSA-UHFFFAOYSA-N 4-(1-oxo-1,4-thiazinan-4-yl)-n-phenyl-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CS(=O)CCN1C(C1=NC=N2)=NC(N3CCNCC3)=NC1=C2NC1=CC=CC=C1 APLDGUGEEOJUSA-UHFFFAOYSA-N 0.000 description 1
- BDSJKAHYJFOELO-UHFFFAOYSA-N 4-(2,8-dichloropyrimido[5,4-d]pyrimidin-4-yl)-1,4-thiazinane 1-oxide Chemical compound C=12N=CN=C(Cl)C2=NC(Cl)=NC=1N1CCS(=O)CC1 BDSJKAHYJFOELO-UHFFFAOYSA-N 0.000 description 1
- FQYNHQXLLUVESJ-UHFFFAOYSA-N 4-(2-piperazin-1-yl-8-thiomorpholin-4-ylpyrimido[5,4-d]pyrimidin-4-yl)-1,4-thiazinane 1-oxide Chemical compound C1CS(=O)CCN1C1=NC(N2CCNCC2)=NC2=C(N3CCSCC3)N=CN=C12 FQYNHQXLLUVESJ-UHFFFAOYSA-N 0.000 description 1
- SVDCYQGNYMKQTP-UHFFFAOYSA-N 4-(8-methylsulfanyl-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-4-yl)-1,4-thiazinane 1-oxide Chemical compound N1=C2C(SC)=NC=NC2=C(N2CCS(=O)CC2)N=C1N1CCNCC1 SVDCYQGNYMKQTP-UHFFFAOYSA-N 0.000 description 1
- CODZCGUUEMPFBY-UHFFFAOYSA-N 4-[2-chloro-8-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-4-yl]-1,4-thiazinane 1-oxide Chemical compound C=12N=CN=C(N3CCS(=O)CC3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 CODZCGUUEMPFBY-UHFFFAOYSA-N 0.000 description 1
- KGNDYJBIRZEBKL-UHFFFAOYSA-N 4-[8-(benzylamino)-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-2-yl]piperazine-1-carbaldehyde Chemical compound C1CN(C=O)CCN1C1=NC(N2CCS(=O)CC2)=C(N=CN=C2NCC=3C=CC=CC=3)C2=N1 KGNDYJBIRZEBKL-UHFFFAOYSA-N 0.000 description 1
- WGUGJMSAPGWHLO-UHFFFAOYSA-N 4-[8-(benzylamino)-4-thiomorpholin-4-ylpyrimido[5,4-d]pyrimidin-2-yl]piperazine-1-carbaldehyde Chemical compound C1CN(C=O)CCN1C1=NC(N2CCSCC2)=C(N=CN=C2NCC=3C=CC=CC=3)C2=N1 WGUGJMSAPGWHLO-UHFFFAOYSA-N 0.000 description 1
- SVDJKNLMRCRXCZ-UHFFFAOYSA-N 4-[8-amino-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-2-yl]piperazine-1-carbaldehyde Chemical compound N1=C2C(N)=NC=NC2=C(N2CCS(=O)CC2)N=C1N1CCN(C=O)CC1 SVDJKNLMRCRXCZ-UHFFFAOYSA-N 0.000 description 1
- FAMGPYQSDWIQPQ-UHFFFAOYSA-N 4-[[2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-yl]amino]butan-1-ol Chemical compound N1=C(Cl)N=C2C(NCCCCO)=NC=NC2=C1N1CCS(=O)CC1 FAMGPYQSDWIQPQ-UHFFFAOYSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- AYMNZLSXQXXFJC-UHFFFAOYSA-N 4-morpholin-4-yl-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C2C(N)=NC=NC2=C(N2CCOCC2)N=C1N1CCNCC1 AYMNZLSXQXXFJC-UHFFFAOYSA-N 0.000 description 1
- SLFGLPOJWLMRER-UHFFFAOYSA-N 4-morpholin-4-yl-n-(2-phenylethyl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCOCC3)N=C(N3CCNCC3)N=C2C=1NCCC1=CC=CC=C1 SLFGLPOJWLMRER-UHFFFAOYSA-N 0.000 description 1
- MPKUFSNDKVVAIA-UHFFFAOYSA-N 4-morpholin-4-yl-n-phenyl-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CNCCN1C1=NC(N2CCOCC2)=C(N=CN=C2NC=3C=CC=CC=3)C2=N1 MPKUFSNDKVVAIA-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BMTAFVWTTFSTOG-UHFFFAOYSA-N Butylate Chemical compound CCSC(=O)N(CC(C)C)CC(C)C BMTAFVWTTFSTOG-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000032109 Transient ischaemic attack Diseases 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 125000002339 acetoacetyl group Chemical group O=C([*])C([H])([H])C(=O)C([H])([H])[H] 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005237 alkyleneamino group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000007957 amaurosis fugax Diseases 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 125000004803 chlorobenzyl group Chemical group 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 125000005805 dimethoxy phenyl group Chemical group 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- KSRHWBLHVZJTKV-UHFFFAOYSA-N iodobenzene dichloride Chemical compound ClI(Cl)C1=CC=CC=C1 KSRHWBLHVZJTKV-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002561 ketenes Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- FYYKKOGYQBXMNA-UHFFFAOYSA-N n,n-dibutyl-2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C(Cl)N=C2C(N(CCCC)CCCC)=NC=NC2=C1N1CCS(=O)CC1 FYYKKOGYQBXMNA-UHFFFAOYSA-N 0.000 description 1
- YPUDHPIDCQSWEG-UHFFFAOYSA-N n,n-diethyl-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C2C(N(CC)CC)=NC=NC2=C(N2CCS(=O)CC2)N=C1N1CCNCC1 YPUDHPIDCQSWEG-UHFFFAOYSA-N 0.000 description 1
- WJEPRSUMAKNJRR-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3C=C4OCOC4=CC=3)C2=NC(Cl)=NC=1N1CCS(=O)CC1 WJEPRSUMAKNJRR-UHFFFAOYSA-N 0.000 description 1
- PPTXMEQKKTWNMU-UHFFFAOYSA-N n-(4-ethoxyphenyl)-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(OCC)=CC=C1NC1=NC=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C12 PPTXMEQKKTWNMU-UHFFFAOYSA-N 0.000 description 1
- DYISPHLHVDPNEL-UHFFFAOYSA-N n-(furan-2-ylmethyl)-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CS(=O)CCN1C(C1=NC=N2)=NC(N3CCNCC3)=NC1=C2NCC1=CC=CO1 DYISPHLHVDPNEL-UHFFFAOYSA-N 0.000 description 1
- HDWHFWDRRIWYCM-UHFFFAOYSA-N n-[(2,4-dichlorophenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound ClC1=CC(Cl)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C12 HDWHFWDRRIWYCM-UHFFFAOYSA-N 0.000 description 1
- NLWJXEQIPYKMHS-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C12 NLWJXEQIPYKMHS-UHFFFAOYSA-N 0.000 description 1
- WCVQZHXBEYMJFF-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(Cl)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C12 WCVQZHXBEYMJFF-UHFFFAOYSA-N 0.000 description 1
- MDARBVLKWSETJR-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(F)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C12 MDARBVLKWSETJR-UHFFFAOYSA-N 0.000 description 1
- UOHYRNYTCOAMMV-UHFFFAOYSA-N n-[(4-methylphenyl)methyl]-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=CC(C)=CC=C1CNC1=NC=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C12 UOHYRNYTCOAMMV-UHFFFAOYSA-N 0.000 description 1
- QWWPIEHAFCFOJT-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C1=NC=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C12 QWWPIEHAFCFOJT-UHFFFAOYSA-N 0.000 description 1
- WGKQZONGDOCUQU-UHFFFAOYSA-N n-benzyl-2-(4-methylpiperazin-1-yl)-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C1CN(C)CCN1C1=NC(N2CCS(=O)CC2)=C(N=CN=C2NCC=3C=CC=CC=3)C2=N1 WGKQZONGDOCUQU-UHFFFAOYSA-N 0.000 description 1
- OVGNGXHLTYJFCF-UHFFFAOYSA-N n-benzyl-2-chloro-4-(1,1-dioxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCS(=O)(=O)CC1 OVGNGXHLTYJFCF-UHFFFAOYSA-N 0.000 description 1
- WBMJEZLHJZMRHV-UHFFFAOYSA-N n-benzyl-2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)-n-propylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C2C=1N(CCC)CC1=CC=CC=C1 WBMJEZLHJZMRHV-UHFFFAOYSA-N 0.000 description 1
- XYQALCZKBXGKAD-UHFFFAOYSA-N n-benzyl-2-chloro-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCOCC1 XYQALCZKBXGKAD-UHFFFAOYSA-N 0.000 description 1
- ZMKVBJJXMVDCDG-UHFFFAOYSA-N n-benzyl-2-chloro-4-thiomorpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=12N=CN=C(NCC=3C=CC=CC=3)C2=NC(Cl)=NC=1N1CCSCC1 ZMKVBJJXMVDCDG-UHFFFAOYSA-N 0.000 description 1
- YYRLNSZZNBPCFI-UHFFFAOYSA-N n-benzyl-2-chloro-n-methyl-4-morpholin-4-ylpyrimido[5,4-d]pyrimidin-6-amine Chemical compound N=1C=C2N=C(Cl)N=C(N3CCOCC3)C2=NC=1N(C)CC1=CC=CC=C1 YYRLNSZZNBPCFI-UHFFFAOYSA-N 0.000 description 1
- FJUKLZQTUCDARC-UHFFFAOYSA-N n-benzyl-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-yl-n-propylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C2C=1N(CCC)CC1=CC=CC=C1 FJUKLZQTUCDARC-UHFFFAOYSA-N 0.000 description 1
- RTENFVSTJRUJTH-UHFFFAOYSA-N n-benzyl-4-morpholin-4-yl-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound C=1C=CC=CC=1CNC(C1=N2)=NC=NC1=C(N1CCOCC1)N=C2N1CCNCC1 RTENFVSTJRUJTH-UHFFFAOYSA-N 0.000 description 1
- OVXXCDFFBAABJS-UHFFFAOYSA-N n-benzyl-n-butyl-2-chloro-4-(1-oxo-1,4-thiazinan-4-yl)pyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(Cl)N=C2C=1N(CCCC)CC1=CC=CC=C1 OVXXCDFFBAABJS-UHFFFAOYSA-N 0.000 description 1
- AORXEJLCRMKTNT-UHFFFAOYSA-N n-benzyl-n-ethyl-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C2C=1N(CC)CC1=CC=CC=C1 AORXEJLCRMKTNT-UHFFFAOYSA-N 0.000 description 1
- RANNBJBRCWPZQS-UHFFFAOYSA-N n-benzyl-n-methyl-2-piperazin-1-yl-4-thiomorpholin-4-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCSCC3)N=C(N3CCNCC3)N=C2C=1N(C)CC1=CC=CC=C1 RANNBJBRCWPZQS-UHFFFAOYSA-N 0.000 description 1
- OYRGENRXGGLSDQ-UHFFFAOYSA-N n-benzyl-n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)-2-phenoxypyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(OC=3C=CC=CC=3)N=C2C=1N(C)CC1=CC=CC=C1 OYRGENRXGGLSDQ-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- MSLZQJWWUWUYPQ-UHFFFAOYSA-N n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N1=C2C(NC)=NC=NC2=C(N2CCS(=O)CC2)N=C1N1CCNCC1 MSLZQJWWUWUYPQ-UHFFFAOYSA-N 0.000 description 1
- OUOIWPGXMKMFRU-UHFFFAOYSA-N n-methyl-4-(1-oxo-1,4-thiazinan-4-yl)-n-phenyl-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCS(=O)CC3)N=C(N3CCNCC3)N=C2C=1N(C)C1=CC=CC=C1 OUOIWPGXMKMFRU-UHFFFAOYSA-N 0.000 description 1
- ZCVIEDCUXLNECP-UHFFFAOYSA-N n-methyl-4-morpholin-4-yl-n-phenyl-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-8-amine Chemical compound N=1C=NC2=C(N3CCOCC3)N=C(N3CCNCC3)N=C2C=1N(C)C1=CC=CC=C1 ZCVIEDCUXLNECP-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000004894 pentylamino group Chemical group C(CCCC)N* 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000003395 phenylethylamino group Chemical group [H]N(*)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 1
- HFFLGKNGCAIQMO-UHFFFAOYSA-N trichloroacetaldehyde Chemical compound ClC(Cl)(Cl)C=O HFFLGKNGCAIQMO-UHFFFAOYSA-N 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Neue 2-(Perhydro-1,4-diazino)-pyrimido 5 ,4-dJpyrimidine, New 2- (perhydro-1,4-diazino) -pyrimido 5, 4-dJpyrimidines,
deren Herstellung und die sie enthaltende Arzneimittel ZZusatz zum DBP (Patentanmeldung P 29 26 804.0L7 Gegenstand der vorliegenden Erfindung sind neue 2-(Perhydro-1,4-diazino)-pyrimido[5,4-d]pyrimidine der allgemeinen Formel deren physiologisch verträgliche Säureadditionssalze mit anorganischen oder organischen Säuren und Verfahren zu ihrer Herstellung sowie die neuen Verbindungen der allgemeinen Formel I enthaltende Arzneimittel.their preparation and the pharmaceuticals containing them ZAddition to the DBP (patent application P 29 26 804.0L7 The present invention relates to new 2- (perhydro-1,4-diazino) pyrimido [5,4-d] pyrimidines of the general formula their physiologically acceptable acid addition salts with inorganic or organic acids and processes for their preparation, as well as medicaments containing the new compounds of general formula I.
Die neuen 2-(Perhydro-1,4-diazino)-pyrimido/5,4-d7pyrimidine und deren physiologisch verträgliche Säureadditionssalze weisen wertvolle pharmakologische Eigenschaften auf, insbesondere antithrombotische Wirkungen.The new 2- (perhydro-1,4-diazino) -pyrimido / 5,4-d7pyrimidines and their Physiologically acceptable acid addition salts have valuable pharmacological Properties, in particular antithrombotic effects.
In der allgemeinen Formel I bedeutet R1 eine Aminogruppe der Formel wobei R4 und R5, die gleich oder verschieden sein können, Wasserstoffatome, Alkylgruppen mit 1 bis 4 Kohlenstoffatomen, wobei jede Alkylgruppe durch eine Hydroxygruppe, eine Alkoxygruppe mit 1 bis 3 Kohlenstoffatomen oder eine Phenylgruppe substituiert sein kann, oder Phenylgruppen' wobei die vorstehend erwähnten Phenylkerne durch eine Methylendioxygruppe monosubstituiert oder durch eine Alkyl- oder Alkoxygruppe mit jeweils 1 bis 3'Kohlenstoffatomen, eine Trifluormethylgruppe, ein Fluor-, Chlor- oder Bromatom mono- oder disubstituiert und die Substituenten des Phenylkerns jeweils gleich oder verschieden sein können, Alkylgruppen mit 5 bis 8 Kohlenstoffatomen, Cycloalkylgruppen mit 5 bis 7 Kohlenstoffatomen, Pyridyl-, Picolyl- oder Furfurylgruppen oder R4 und R5 zusammen mit dem dazwischenliegenden Stickstoffatom eine Alkylenaminogruppe mit 4 bis 6 Kohlenstoffatomen, eine Thiomorpholino- oder Thiomorpholino-1-oxidgruppe, R2 eine gegebenenfalls durch 1 oder 2 Methylgruppen substituierte Thiomorpholino-, Thiomorpholino-1-oxid- oder Thiomorpholino-1,1-dioxidgruppe oder einer der Reste R1 oder R2 auch eine gegebenenfalls durch 1 oder 2 Methylgruppen substituierte Morpholinogruppe, R3 ein Wasserstoffatom, eine gegebenenfalls durch eine Hydroxygruppe substituierte Alkylgruppe mit 1 bis 4 Kohlenstoffatomen, eine gegebenenfalls durch eine Carboxy-, Methoxy-, oder Acetylgruppe substituierte Alkanoylgruppe mit 2 bis 4 Kohlenstoffatomen, eine Formyl- oder Furoylgruppe und n die Zahl 2 oder 3.In general formula I, R1 denotes an amino group of the formula where R4 and R5, which can be the same or different, hydrogen atoms, alkyl groups having 1 to 4 carbon atoms, each alkyl group being substituted by a hydroxyl group, an alkoxy group having 1 to 3 carbon atoms or a phenyl group, or phenyl groups where the above-mentioned phenyl nuclei monosubstituted by a methylenedioxy group or monosubstituted or disubstituted by an alkyl or alkoxy group each having 1 to 3 'carbon atoms, a trifluoromethyl group, a fluorine, chlorine or bromine atom and the substituents of the phenyl nucleus can each be the same or different, alkyl groups having 5 to 8 carbon atoms, cycloalkyl groups with 5 to 7 carbon atoms, pyridyl, picolyl or furfuryl groups or R4 and R5 together with the intermediate nitrogen atom an alkyleneamino group with 4 to 6 carbon atoms, a thiomorpholino or thiomorpholino-1-oxide group, R2 an optionally through 1 or 2 substituted methyl groups Thiomorpholino, thiomorpholino-1-oxide or thiomorpholino-1,1-dioxide group or one of the radicals R1 or R2 also a morpholino group optionally substituted by 1 or 2 methyl groups, R3 a hydrogen atom, an optionally substituted by a hydroxyl group with 1 to 4 Carbon atoms, an alkanoyl group with 2 to 4 carbon atoms which is optionally substituted by a carboxy, methoxy or acetyl group, a formyl or furoyl group and n is the number 2 or 3.
Für die bei der Definition der Reste R1, R2 und R3 eingangs erwähnten Bedeutungen kommt somit für R1 die Bedeutung der Amino-, Methylamino-, Athylamino-, Propylamino-, Isopropylamino-, Butylamino-, Isobutylamino-, Pentylamino-, Isopentylamino-, tert.Pentylamino-, Hexylamino-, Heptylamino-, Octylamino-, Cyclopentylamino-, Cyclohexylamino-, Cycloheptylamino-, Hydroxyäthylamino-, 3-Hydroxypropylamino-, 2-Hydroxypropylamino-, 4-Hydroxybutylamino-, 5-Hydroxypentylamino-, 8-Hydrqxyoctylamino-, Benzylamino-, Fluorbenzylamino-, Chlorbenzylamino-, Brombenzylamino-, Methylbenzylamino-, Methoxybenzylamino-, Difluorbenzylamino-, Dichlorbenzylamino-, Dibrombenzylamino-, Dimethoxybenzylamino-, Methylendioxybenzylamino-, Brom-chlor-benzylamino-, Brom-methoxybenzylamino-, 1-Phenyl-äthylamino-, 2-Phenyläthylamino-, 2-Dimethoxyphenyl-äthylamino-, 1 -Phenylpropylamino-, 3-Phenylpropylamino-, 2-Phenylbutylamino- r 4-Phenyl-butylamino-, Phenylamino-, Methoxyphenylamino-, Athoxyphenylamino-, Trifluorphenylamino-, Pyridylamino-, Picoylamino-, Furfurylamino-, N-Methyl-phenylamino-, N-Methyl-pyridylamino-, N-Methyl-picolylamino-, N-Methyl-benzylamino-, N-Xthylbenzylamino-, N-Propyl-benzylamino-, N-Isopropyl-benzylamino-, N-Butyl-benzylamino-, N-Pentyl-benzylamino-, N-Octyl-benzylamino-, N-Hydroxyäthyl-benzylamino-, N-Hydroxypropyl-benzylamino-, N-Hydroxybutyl-benzylamino-1 N-Methyl- 2- (dimethoxyphenyl) -äthylamino-, Dimethylamino-, Diäthylamino-, Dipropylamino-, Diisopropylamino-, Dibutylamino-, Dipentylamino-, Dihexylamino-, Diheptylamino -, Methyl-äthylamino-, Methyl-propylamino-, Äthylpropylamino-, Äthyl-isopropylamino-, Diäthanolamino-, N-Hydroxyäthyl-methoxyäthylamino-, Dihydroxypropylamino-, Pyrrolidino-, Piperidino-, Hexamethylenimino-, Thiomorpholino-, Thiomorpholino-1 -oxid-, Morpholino-, Methylmorpholino- oder Dimethylmorpholinogruppe, für R2 die der Morpholino-, Methylmorpholino-, Dimethylmorpholino-, Thiomorpholino-, Methyl-thiomorpholino-, Thiomorpholino-1-oxid-, Dimethylthiomorpholino-)-oxid- oder Thiomorpholino-1 ,1-dioxidgruppe und für R3 die des Wasserstoffatoms, der Methyl-, Äthyl-, Propyl-, Isopropyl-, Butyl-, Pentyl-, 2-Hydroxyäthyl-, 3-Hydroxypropyl-, 4-Hydroxybutyl-, 2-Hydroxypropyl-, Formyl-, Acetyl-, Propionyl-, Butyroyl-, Acetoacetyl-, Methoxyacetyl- oder Furanoylgruppe in Betracht.For those mentioned at the beginning in the definition of the radicals R1, R2 and R3 Meanings thus comes for R1 the meaning of the amino, methylamino, ethylamino, Propylamino, isopropylamino, butylamino, isobutylamino, pentylamino, isopentylamino, tert.pentylamino, hexylamino, heptylamino, octylamino, cyclopentylamino, cyclohexylamino, Cycloheptylamino, hydroxyethylamino, 3-hydroxypropylamino, 2-hydroxypropylamino, 4-hydroxybutylamino, 5-hydroxypentylamino, 8-hydroxyoctylamino, benzylamino, Fluorobenzylamino, chlorobenzylamino, bromobenzylamino, methylbenzylamino, methoxybenzylamino, Difluorobenzylamino, dichlorobenzylamino, dibromobenzylamino, dimethoxybenzylamino, Methylenedioxybenzylamino-, bromo-chloro-benzylamino-, bromo-methoxybenzylamino-, 1-phenyl-ethylamino-, 2-phenylethylamino, 2-dimethoxyphenylethylamino, 1-phenylpropylamino, 3-phenylpropylamino, 2-phenylbutylamino- r 4-phenyl-butylamino-, phenylamino-, methoxyphenylamino-, athoxyphenylamino-, Trifluorophenylamino, pyridylamino, picoylamino, furfurylamino, N-methyl-phenylamino, N-methyl-pyridylamino-, N-methyl-picolylamino-, N-methyl-benzylamino-, N-Xthylbenzylamino-, N-propyl-benzylamino-, N-isopropyl-benzylamino-, N-butyl-benzylamino-, N-pentyl-benzylamino-, N-octyl-benzylamino-, N-hydroxyethyl-benzylamino-, N-hydroxypropyl-benzylamino-, N-Hydroxybutyl-benzylamino-1 N-methyl- 2- (dimethoxyphenyl) -äthylamino-, dimethylamino-, Diethylamino, dipropylamino, diisopropylamino, dibutylamino, dipentylamino, Dihexylamino, diheptylamino -, methyl ethylamino, methyl propylamino, Ethylpropylamino, ethyl isopropylamino, diethanolamino, N-hydroxyethyl methoxyethylamino, Dihydroxypropylamino, pyrrolidino, piperidino, hexamethyleneimino, thiomorpholino, Thiomorpholino-1 -oxide, morpholino, methylmorpholino or dimethylmorpholino group, for R2 the morpholino, methylmorpholino, dimethylmorpholino, thiomorpholino, Methyl thiomorpholino, thiomorpholino-1-oxide, dimethylthiomorpholino -) - oxide or Thiomorpholino-1, 1-dioxide group and for R3 that of the hydrogen atom, the methyl, Ethyl, propyl, isopropyl, butyl, pentyl, 2-hydroxyethyl, 3-hydroxypropyl, 4-hydroxybutyl, 2-hydroxypropyl, formyl, acetyl, propionyl, butyroyl, acetoacetyl, Methoxyacetyl or furanoyl group into consideration.
Bevorzugte Verbindungen der allgemeinen Formel I sind diejenigen, in der R1 eine Piperidino-, Thiormorpholino- oder Thiomorpholino-1-oxidgruppe, eine Amino-, Alkylamino-, N,N-Dialkylamino-, Phenylalkylamino-, N-Alkyl-phenylalkylamino-, Phenylamino-oder N-Alkyl-phenylaminogruppe, wobei der Alkylteil jeweils 1 bis 4 Kohlenstoffatome enthalten und durch eine Hydroxy-oder Methoxygruppe substituiert sein kann und die vorstehend erwähnten Phenylkerne jeweils durch eine Methyl-, Methoxy-, Äthoxy-, Trifluormethylgruppe, ein Fluor- oder Chloratom mono- oder disubstituiert sein können, eine Alkylaminogruppe mit 5 bis 8 Kohlenstoffatomen, eine Cyclohexylamino-, Picolylamino-, N-Methyl-picolylamino- oder Furfurylaminogruppe, R2 die Thiomorpholino-, Thiomorpholino-1-oxid- oder Thiomorpholino-1,1-dioxidgruppe oder einer der Reste R1 oder R2 auch die Morpholinogruppe, R3 ein Wasserstoffatom, eine gegebenenfalls durch eine Hydroxygruppe substituierte Alkylgruppe mit 1 bis 3 Kohlenstoffatome eine Formyl- oder Furanoylgruppe und n die Zahl 2 bedeuten.Preferred compounds of the general formula I are those in which R1 is a piperidino, thiormorpholino or thiomorpholino-1-oxide group, a Amino, alkylamino, N, N-dialkylamino, phenylalkylamino, N-alkyl-phenylalkylamino, Phenylamino or N-alkyl-phenylamino group, the alkyl part in each case from 1 to 4 Containing carbon atoms and substituted by a hydroxy or methoxy group can be and the above-mentioned phenyl nuclei are each replaced by a methyl, methoxy, Ethoxy, trifluoromethyl group, a fluorine or chlorine atom mono- or disubstituted can be an alkylamino group with 5 to 8 carbon atoms, a cyclohexylamino, Picolylamino, N-methyl-picolylamino or furfurylamino group, R2 the thiomorpholino, Thiomorpholino-1-oxide or thiomorpholino-1,1-dioxide group or one of the radicals R1 or R2 also the morpholino group, R3 is a hydrogen atom, a alkyl group having 1 to 3 carbon atoms which is optionally substituted by a hydroxyl group a formyl or furanoyl group and n is the number 2.
Erfindungsgemäß erhält man die neuen Verbindungen der obigen allgemeinen Formel I nach folgenden Verfahren: a) Umsetzung eines Pyrimidog5,4-dSpyrimidins der allgemeinen Formel in der R1 und R2 wie eingangs definiert sind und X eine nukleophile Austrittsgruppe darstellt, mit einem Perhydro-1,4-diazin der allgemeinen Formel in der n wie eingangs definiert ist und R3' eine leicht abspaltbare Schutzgruppe darstellt oder die für R3 eingangs erwähnten Bedeutungen besitzt, und gegebenenfalls Abspaltung eines verwendeten Schutzrestes.According to the invention, the new compounds of the above general formula I are obtained by the following process: a) Reaction of a pyrimidog5,4-d-pyrimidine of the general formula in which R1 and R2 are as defined at the outset and X represents a nucleophilic leaving group, with a perhydro-1,4-diazine of the general formula in which n is as defined at the beginning and R3 'represents an easily cleavable protective group or has the meanings mentioned for R3 at the beginning, and optionally cleavage of a protective radical used.
Als nukleophile Austrittsgruppe kommt beispielsweise ein Halogenatom wie ein Chlor- oder Bromatom, eine substituierte Hydroxygruppe wie die Phenoxygruppe oder eine Sulfonylgruppe wie die Methylsulfonylgruppe und als leicht abspaltbarer Schutzrest beispielsweise die Trimethylsilylgruppe, ein Kohlensäureesterrest wie die Carbäthoxygruppe oder eine Alkanoylgruppe wie die Formylgruppe in Betracht. A halogen atom, for example, is used as a nucleophilic leaving group such as a chlorine or bromine atom, a substituted hydroxyl group such as the phenoxy group or a sulfonyl group such as the methylsulfonyl group and as easily split off Protective radical, for example the trimethylsilyl group, a carbonic acid ester radical such as the carbethoxy group or an alkanoyl group such as the formyl group.
Die Umsetzung wird zweckmäßigerweise in einem inerten Lösungsmittel wie Aceton, Methyl-äthylketon, Tetrahydrofuran, Dioxan, Chlorbenzol, Dimethylformamid oder Dimethylsulfoxid gegebenenfalls in Gegenwart einer anorganischen Base, z.B. The reaction is expediently carried out in an inert solvent such as acetone, methyl ethyl ketone, tetrahydrofuran, dioxane, chlorobenzene, dimethylformamide or dimethyl sulfoxide, optionally in the presence of an inorganic base, e.g.
Natriumkarbonat oder Kaliumhydroxid, oder einer tertiären organischen Base, z.B. Triäthylamin oder Pyridin, wobei letztere gleichzeitig auch als Lösungsmittel dienen können, und gegebenenfalls in Gegenwart eines Reaktionsbeschleunigers wie eines Kupfersalzes bei Temperaturen zwischen 20 und 1500C, vorzugsweise jedoch bei Temperaturen zwischen 30 und 1000C, durchgeführt. Die Umsetzung kann jedoch auch ohne Lösungsmittel oder in einem Überschuß der eingesetzten Verbindung der allgemeinen Formel III durchgeführt werden. Sodium carbonate or potassium hydroxide, or a tertiary organic Base, e.g. triethylamine or pyridine, the latter also acting as a solvent can serve, and optionally in the presence of a reaction accelerator such as a copper salt at temperatures between 20 and 1500C, but preferably at Temperatures between 30 and 1000C. However, the implementation can also without solvent or in an excess of the compound used in general Formula III can be carried out.
Die anschließende Abspaltung eines Schutzrestes erfolgt zweckmäßigerweise hydroyltisch in Gegenwart einer Säure oder Base in einem wässrigen Lösungsmittel wie Wasser/Methanol oder Wasser/Äthanol und vorzugsweise bei der Siedetemperatur des Reaktionsgemisches. The subsequent cleavage of a protective residue is expedient hydrolytically in the presence of an acid or base in an aqueous solvent such as water / methanol or water / ethanol and preferably at the boiling point of the reaction mixture.
b) Umsetzung eines Pyrimidot5,4-d7pyrimidins der allgemeinen Formel in der R2, R3 und n wie eingangs definiert sind und Y eine niedere Alkylgruppe oder eine Aralkylgruppe darstellt, mit einem Amin der allgemeinen Formel in der R4 und R5 wie eingangs definiert sind, wobei jedoch die Reste R4 und R5 nicht gleichzeitig je ein Wasserstoffatom bedeuten können.b) Implementation of a pyrimidote5,4-d7pyrimidine of the general formula in which R2, R3 and n are as defined at the outset and Y represents a lower alkyl group or an aralkyl group, with an amine of the general formula in which R4 and R5 are as defined at the outset, but the radicals R4 and R5 cannot each represent a hydrogen atom at the same time.
Für Y kommt beispielsweise die Bedeutung der Methyl-, Äthyl-, Propyl-, Benzyl-, Methylbenzyl-, Chlorbenzyl-, Nitrobenzyl-oder Naphthylmethylgruppe in Betracht. For Y comes, for example, the meaning of the methyl, ethyl, propyl, Benzyl, methylbenzyl, chlorobenzyl, nitrobenzyl or naphthylmethyl groups are suitable.
Die Umsetzung wird zweckmäßigerweise in einem Lösungsmittel wie Aceton, Chloroform, Benzol, Tetrahydrofuran, Dimethylformamid oder Äthanol oder in einem Überschuß des eingesetzten Amins der allgemeinen Formel V gegebenenfalls in einem Druckgefäß bei Temperaturen zwischen 100 und 2000C, vorzugsweise jedoch bei Temperaturen zwischen 130 und 1800C, durchgeführt. The reaction is expediently carried out in a solvent such as acetone, Chloroform, benzene, tetrahydrofuran, dimethylformamide or ethanol or in one Excess of the amine of the general formula V used, optionally in one Pressure vessel at temperatures between 100 and 2000C, but preferably at temperatures between 130 and 1800C.
Die Umsetzung kann jedoch auch ohne Lösungsmittel durchgeführt werden. However, the reaction can also be carried out without a solvent.
c) Zur Herstellung von Verbindungen der allgemeinen Formel I, in der mindestens einer der Reste R4 oder R5 kein Wasserstoffatom darstellt: Umsetzung eines Pyrimido5,4-d7pyrimidins der allgemeinen Formel in der R2 und n wie eingangs definiert sind, R3" eine leicht abspaltbare Schutzgruppe oder mit Ausnahme von Wasserstoff die für R3 eingangs erwähnten Bedeutungen besitzt und A eine Gruppe der Formel - NH - R4 darstellt, wobei R4 wie eingangs definiert ist, mit einer Verbindung der allgemeinen Formel Z - R5' , (VII) in der Z eine nukleophile Austrittsgruppe wie ein Halogenatom oder ein Sulfonsäureesterrest und R51 mit Ausnahme des Wasserstoffatoms und einer gegebenenfalls durch Hydroxy-, Alkyl-, Alkoxy-, Trifluormethyl-, Fluor-, Chlor- und/oder Bromatome mono- oder disubstituierten Phenylgruppe oder durch eine Methylendioxygruppe substituierten Phenylgruppe die für R5 eingangs erwähnten Bedeutungen besitzt, und gegebenenfalls anschließende Abspaltung eines Schutzrestes.c) For the preparation of compounds of the general formula I in which at least one of the radicals R4 or R5 does not represent a hydrogen atom: conversion of a pyrimido5,4-d7pyrimidine of the general formula in which R2 and n are as defined at the outset, R3 "is an easily cleavable protective group or, with the exception of hydrogen, has the meanings mentioned for R3 at the beginning and A represents a group of the formula —NH — R4, where R4 is as defined at the outset, with a compound of the general formula Z - R5 ', (VII) in which Z is a nucleophilic leaving group such as a halogen atom or a sulfonic acid ester radical and R51 with the exception of the hydrogen atom and an optionally substituted by hydroxy, alkyl, alkoxy, trifluoromethyl, fluorine, chlorine and / or bromine atoms mono- or disubstituted phenyl group or phenyl group substituted by a methylenedioxy group has the meanings mentioned for R5 at the beginning, and optionally subsequent cleavage of a protective radical.
Als nukleophile Austrittsgruppe kommt beispielsweise das Chlor-, Brom- oder Jodatom, die Methylsulfonyloxy-, Methoxysulfonyloxy- oder p-Toluolsulfonyloxygruppe und als leicht abspaltbarer Schutzrest die Trimethylsilylgruppe, ein Kohlensäureesterrest wie die Carbäthoxygruppe oder eine Alkanoylgruppe wie die Formylgruppe in Betracht.As a nucleophilic leaving group, for example, the chlorine, bromine or iodine atom, the methylsulfonyloxy, methoxysulfonyloxy or p-toluenesulfonyloxy group and the trimethylsilyl group, a carbonic acid ester residue, as an easily removable protective residue such as the carbethoxy group or an alkanoyl group such as the formyl group.
Die Umsetzung wird zweckmäßigerweise in einem Lösungsmittel wie Aceton, Methyl-Sthylketon, Methylenchlorid, Chloroform, Tetrahydrofuran, Dioxan, Dimethylformamid oder Dimethylsulfoxid gegebenenfalls in Gegenwart einer Base wie Natriumkarbonat, Natriumhydroxid, Kaliumhydroxid, Kalium-tert.butylat, Triäthylamin oder Pyridin, wobei letztere gleichzeitig auch als Lösungsmittel dienen können, und gegebenenfalls in Gegenwart eines Reaktionsbeschleunigers wie einem Alkalijodid, z.B.The reaction is expediently carried out in a solvent such as acetone, Methyl ethyl ketone, methylene chloride, chloroform, tetrahydrofuran, dioxane, dimethylformamide or dimethyl sulfoxide, optionally in the presence of a base such as sodium carbonate, Sodium hydroxide, potassium hydroxide, potassium tert-butoxide, triethylamine or pyridine, the latter can also serve as a solvent at the same time, and optionally in the presence of a reaction accelerator such as an alkali iodide, e.g.
Kaliumjodid, bei Temperaturen zwischen 0 und 1000C, vorzugsweise jedoch bei Temperaturen zwischen 20 und 800C, durchgeführt. Die Umsetzung kann jedoch auch ohne Lösungsmittel oder in einem Überschuß der eingesetzten Verbindung der allgemeinen Formel VII durchgeführt werden.Potassium iodide, at temperatures between 0 and 1000C, but preferably at temperatures between 20 and 800C carried out. However, the implementation can also without solvent or in an excess of the compound used in general Formula VII can be carried out.
Die anschließende Abspaltung eines Schutzrestes erfolgt zweckmäßigerweise hydroyltisch in Gegenwart einer Säure oder Base in einem wässrigen Lösungsmittel wie Wasser/Methanol oder Wasser/0thanol und vorzugsweise bei der Siedetemperatur des Reaktionsgemisches.The subsequent cleavage of a protective residue is expedient hydrolytically in the presence of an acid or base in an aqueous solvent such as water / methanol or water / ethanol and preferably at the boiling point of the reaction mixture.
Erhält man erfindungsgemäß eine Verbindung der allgemeinen Formel I, in der R3 eine gegebenenfalls durch eine Methoxy-, Acetyl- oder Carboxylgruppe substituierte Alkanoylgruppe mit 2 bis 4 Kohlenstoffatomen, eine Formyl- oder Furoylgruppe darstellt, so kann diese mittels Hydrolyse in eine entsprechende Verbindung der allgemeinen Formel I, in der R3 ein Wasserstoffatom darstellt, übergeführt werden oder eine Verbindung der allgemeinen Formel I, in der R3 ein Wasserstoffatom darstellt, so kann diese mittels Acylierung in eine entsprechende Verbindung der allgemeinen Formel I, in der R3 eine gegebenenfalls durch eine Carboxy-, Methoxy-oder Acetylgruppe substituierte Alkanoylgruppe mit 2 bis 4 Kohlenstoffatomen, eine Formyl- oder Furoylgruppe darstellt, übergeführt werden oder eine Verbindung der allgemeinen Formel I, in der R1 eine Thiomorpholinogruppe und/oder R2 eine gegebenenfalls durch 1 Oder 2 Methylgruppen substituierte Thiomorpholinogruppe darstellen, mittels Oxidation in eine entsprechende Thiomorpholino-1,oxid- bzw. Thiomorpholino-1 ,1-dioxidverbindung der allgemeinen Formel I übergeführt werden.According to the invention, a compound of the general formula is obtained I, in which R3 is optionally replaced by a methoxy, acetyl or carboxyl group substituted alkanoyl group with 2 to 4 carbon atoms, a formyl or furoyl group represents, this can by means of hydrolysis into a corresponding compound of general formula I, in which R3 represents a hydrogen atom, are converted or a compound of the general formula I in which R3 represents a hydrogen atom, this can be converted into a corresponding compound of the general by means of acylation Formula I in which R3 is optionally substituted by a carboxy, methoxy or acetyl group substituted alkanoyl group with 2 to 4 carbon atoms, a formyl or furoyl group represents, be transferred or a compound of general Formula I, in which R1 is a thiomorpholino group and / or R2 is optionally a Represent 1 or 2 methyl groups substituted thiomorpholino group, by means of oxidation into a corresponding thiomorpholino-1, oxide or thiomorpholino-1, 1-dioxide compound of the general formula I can be converted.
Die nachträgliche Hydrolyse wird zweckmäßigerweise in einem wässrigen Lösungsmittel wie Wasser, Wasser/Äthanol, Wasser/Isopropanol oder Wasser/Dioxan in Gegenwart einer Säure wie Salzsäure oder Schwefelsäure oder einer Base wie Natron- oder Kalilauge bei erhöhten Temperaturen, vorzugsweise jedoch bei der Siedetemperatur des Reaktionsgemisches, durchgeführt.The subsequent hydrolysis is expediently carried out in an aqueous Solvents such as water, water / ethanol, water / isopropanol or water / dioxane in the presence of an acid such as hydrochloric acid or sulfuric acid or a base such as sodium or potassium hydroxide solution at elevated temperatures, but preferably at the boiling point of the reaction mixture carried out.
Die nachträgliche Acylierung wird zweckmäßigerweise in einem Lösungsmittel wie Dimethylformamid, Tetrahydrofuran, Dioxan, Methylenchlorid, Chloroform oder Toluol mit einer entsprechenden Carbonsäure oder deren reaktionsfähigen Derivaten wie deren Anhydride, Säurehalogenide, Ketene, 1-Imidazolyl-derivate oder mit deren gemischten Anhydriden mit Carbonsäuren oder Kohlensäureestern gegebenenfalls in Gegenwart eines säureaktivierenden und/ oder wasserentziehenden Mittels, z.B. Chlorameisensäureäthylester, Thionylchlorid, N,N'-Dicyclohexylcarbodiimid oder N,N'-Carbonyldiimidazol, und gegebenenfalls in Gegenwart einer anorganischen Base wie Natriumcarbonat oder tertiären organischen Base wie Triäthylamin oder Pyridin, welche gleichzeitig auch als Lösungsmittel dienen können, bei Temperaturen zwischen -25 und 1200C, vorzugsweise jedoch bei Temperaturen zwischen 0 und 50tC, durchgeführt. Besonders vorteilhaft wird jedoch die Formylierung mit Chloral durchgeführt.The subsequent acylation is expediently carried out in a solvent such as dimethylformamide, tetrahydrofuran, dioxane, methylene chloride, chloroform or Toluene with a corresponding carboxylic acid or its reactive derivatives such as their anhydrides, acid halides, ketenes, 1-imidazolyl derivatives or with their mixed anhydrides with carboxylic acids or carbonic acid esters, optionally in Presence of an acid-activating and / or dehydrating agent, e.g. ethyl chloroformate, Thionyl chloride, N, N'-dicyclohexylcarbodiimide or N, N'-carbonyldiimidazole, and optionally in the presence of an inorganic base such as sodium carbonate or tertiary organic Base such as triethylamine or pyridine, which also serve as solvents can, at temperatures between -25 and 1200C, but preferably at temperatures between 0 and 50tC. However, formylation is particularly advantageous performed with chloral.
Die nachträgliche Oxidation wird vorzugsweise in einem Lösungsmittel, z.B. Wasser, Wasser/Pyridin, Eisessig oder Methanol, je nach dem verwendeten Oxidationsmittel zweckmäßigerweise bei Temperaturen zwischen -80 und 1000C durchgeführt.The subsequent oxidation is preferably carried out in a solvent, e.g. water, water / pyridine, glacial acetic acid or methanol, depending on the oxidizing agent used expediently carried out at temperatures between -80 and 1000C.
Zur Herstellung der Thiomorpholino-1-oxide der allgemeinen Formel I wird die nachträgliche Oxidation zweckmäßigerweise mit einem Äquivalent des verwendeten Oxidationsmittels durchgeführt, z.B. mit Wasserstoffperoxid in Eisessig bei O bis 200C, mit einer Persäure wie Peressigsäure, m-Chlorperbenzoesäure oder Peroxytrifluoressigsäure bei 0 bis 50°C, mit Natriummetaperjodat in wässrigem Methanol oder Äthanol bei 15 bis 250C, mit tert.-Butylhypochlorit in Methanol bei -80 bis -300C, mit Jodbenzoldichlorid in wässrigem Pyridin bei O bis 500C, mit Salpetersäure in Eisessig b ei 0 bis 20°C, mit Chromsäure in Eisessig oder Aceton bei 0 bis 20°C und mit Sulfurylchlorid in Methylenchlorid bei -7O0C, der hierbei erhaltene Thioäther-Chlor-Komplex wird zweckmäßigerweise mit wässrigem Äthanol hydrolysiert.For the preparation of the thiomorpholino-1-oxides of the general formula I the subsequent oxidation is expediently with an equivalent of the one used Oxidizing agent carried out, e.g. with hydrogen peroxide in glacial acetic acid at 0 bis 200C, with a peracid such as peracetic acid, m-chloroperbenzoic acid or peroxytrifluoroacetic acid at 0 to 50 ° C, with sodium metaperiodate in aqueous methanol or ethanol at 15 up to 250C, with tert-butyl hypochlorite in methanol at -80 to -300C, with iodobenzene dichloride in aqueous pyridine at 0 to 500C, with nitric acid in glacial acetic acid at 0 to 20 ° C, with chromic acid in glacial acetic acid or acetone at 0 to 20 ° C and with sulfuryl chloride in Methylene chloride at -7O0C, the thioether-chlorine complex obtained here is expedient hydrolyzed with aqueous ethanol.
Zur Herstellung der Thiomorpholino-1,1-dioxide der allgemeinen Formel I wird die nachträgliche Oxidation zweckmäßigerweise mit zwei Äquivalenten des betreffenden Oxidationsmittels ausgehend von einer Thiomorpholinoverbindung der allgemeinen Formel I bzw.For the preparation of the thiomorpholino-1,1-dioxides of the general formula I is the subsequent oxidation expediently with two equivalents of the relevant Oxidizing agent based on a thiomorpholino compound of the general formula I or
mit einem Äquivalent ausgehend von einer Thiomorpholino-1-oxidverbindung der allgemeinen Formel I analog wie oben beschrieben durchgeführt. Die Umsetzung wird jedoch bei einer um 10-50°C höheren Temperatur durchgeführt.with one equivalent starting from a thiomorpholino-1-oxide compound of the general formula I carried out analogously as described above. The implementation however, it is carried out at a temperature that is 10-50 ° C higher.
Desweiteren lassen sich die neuen Verbindungen der allgemeinen Formel I in ihre physiologisch verträglichen Säureadditionssalze mit anorganischen oder organischen Säuren überführen. Als Säuren haben sich beispielsweise Salzsäure, Bromwasserstoffsäure, Schwefelsäure, Phosphorsäure, Methansulfonsäure, p-Toluolsulfonsäure, Essigsäure, Milchsäure, Zitronensäure, Weinsäure, Bernsteinsäure, Maleinsäure, Fumarsäure oder Salicylsäure als geeignet erwiesen.Furthermore, the new compounds of the general formula I in their physiologically compatible acid addition salts with inorganic or transfer organic acids. As acids, for example, hydrochloric acid, hydrobromic acid, Sulfuric acid, phosphoric acid, methanesulfonic acid, p-toluenesulfonic acid, acetic acid, Lactic acid, citric acid, tartaric acid, succinic acid, maleic acid, or fumaric acid Salicylic acid found suitable.
Die als Ausgangsstoffe verwendeten Verbindungen der allgemeinen Formeln II und IV erhält man durch stufenweisen Ersatz der Chloratome des 2,4,8-Trichlor-pyrimidot5,4-dSpyrimidins (siehe DE-PS 1 116 676), die als Ausgangsstoffe verwendeten Verbindungen der allgemeinen Formeln II und IV werden in den Beispielen beschrieben und die als Ausgangsstoffe verwendeten Verbindungen der allgemeinen Formeln III, V und VII sind literaturbekannt bzw. werden nach an sich bekannten Verfahren erhaltene Die als Ausgangsstoffe verwendeten Verbindungen der allgemeinen Formel VI erhält man zweckmäßigerweise gemäß Verfahren a) der vorliegenden Erfindung.The compounds of the general formulas used as starting materials II and IV are obtained by gradually replacing the chlorine atoms of the 2,4,8-trichloropyrimidote5,4-d-pyrimidine (see DE-PS 1 116 676), the compounds used as starting materials the General formulas II and IV are described in the examples and used as starting materials Compounds of the general formulas III, V and VII used are known from the literature The used as starting materials are obtained by processes known per se Compounds of the general formula VI are expediently obtained according to processes a) of the present invention.
Wie bereits eingangs erwähnt, weisen die erfindungsgemäß hergestellten neuen Verbindungen der allgemeinen Formel I und deren physiologisch verträgliche Säureadditionssalze wertvolle pharmakologische Eigenschaften auf, insbesondere antithrombotische Eigenschaften. Außerdem weisen diese eine PDE-Hemmwirkung und eine Hemmwirkung auf die Aggregation von in die Blutbahn geschwemmten Krebszellen auf.As already mentioned at the outset, those produced according to the invention have new compounds of general formula I and their physiologically acceptable Acid addition salts have valuable pharmacological properties, especially antithrombotic Properties. In addition, they have a PDE inhibitory effect and an inhibitory effect the aggregation of cancer cells washed into the bloodstream.
Auf Grund ihrer pharmakologischen Eigenschaften eignen sich die Verbindungen der allgemeinen Formel I sowie deren physiologisch verträgliche Säureadditionssalze mit anorganischen oder organischen Säuren zur Prophylaxe thrombo-embolischer Erkrankungen wie Coronarinfarkt, Cerebralinfarkt, sogn. transient ischaemic attacks, Amaurosis fugax und zur Prophylaxe der Arteriosklerose und der Metastasenbildung. Hierzu lassen sich diese, gegebenenfalls in Kombination mit anderen Wirksubstanzen, in die üblichen pharmazeutischen Zubereitungsformen wie Dragees, Tabletten, Kapseln, Suppositorien, Lösungen oder Suspensionen einarbeiten.The compounds are suitable on the basis of their pharmacological properties of the general formula I and their physiologically acceptable acid addition salts with inorganic or organic acids for the prophylaxis of thrombo-embolic diseases like coronary infarction, cerebral infarction, sogn. transient ischaemic attacks, amaurosis fugax and for the prophylaxis of arteriosclerosis and the formation of metastases. To do this, let these, possibly in combination with other active substances, in the usual pharmaceutical preparation forms such as dragees, tablets, capsules, suppositories, Incorporate solutions or suspensions.
Die Einzeldosis am Erwachsenen beträgt hierbei 0,1 - 20 mg, vorzugsweise 0,5 - 5 mg, 2 - 4 x täglich und somit die Tagesdosis 0,2 - 80 mg.The single dose for adults is 0.1-20 mg, preferably 0.5 - 5 mg, 2 - 4 times a day and thus the daily dose 0.2 - 80 mg.
Die nachfolgenden Beispiele sollen die Erfindung näher erläutern: Vorbemerkung: Bei den Schmelzpunktangaben handelt es sich um unkorrigierte Schmelzpunkte.The following examples are intended to explain the invention in more detail: Preliminary remark: The melting point data are uncorrected melting points.
Beispiele zur Herstellung der Ausgangsverbindungen: Beispiel A 2, 8-ichlor-4-morpholino-pyrimidoL5,4-djpyrimidin 118 g (0,5 Mol) 2,4,8-Trichlor-pyrimidoL5,4-dçpyrimidin werden in 1,2 1 Aceton suspendiert und anschließend unter Rühren bei Raumtemperatur eine Lösung von 44 ml (0,5 Mol) Morpholin und 70 ml (0,5 Mol) Triäthylamin in 100 ml Aceton langsam zulaufen gelassen. Nach anschließendem etwa halbstündigem Rühren gibt man zum Reaktionsgemisch 1,3 1 Wasser, wobei sich das Triathylaminhydrochlorid auflöst und weiteres Reaktionsprodukt abscheidet. Nach einigem Stehen wird abgesaugt, der Niederschlag gut mit Wasser und dann mit etwas Methanol gewaschen und bei 6O0C getrocknet.Examples for the preparation of the starting compounds: Example A 2, 8-chloro-4-morpholino-pyrimidoL5,4-djpyrimidine 118 g (0.5 mol) 2,4,8-trichloro-pyrimidoL5,4-dupyrimidine are suspended in 1.2 l of acetone and then with stirring at room temperature a solution of 44 ml (0.5 mol) of morpholine and 70 ml (0.5 mol) of triethylamine in 100 ml of acetone slowly run in. After stirring for about half an hour 1.3 l of water are added to the reaction mixture, the triethylamine hydrochloride being formed dissolves and separates further reaction product. After standing for a while, suction is performed, the precipitate was washed well with water and then with a little methanol and heated at 60.degree dried.
Ausbeute: 132 g (92 % der Theorie) vom Schmelzpunkt 179-181 0C, Schmelzpunkt: 183 - 1850C (aus Äthanol) Die Umsetzung kann in völlig analoger Weise auch unter Verwendung einer wässrigen Kaliumcarbonat-Lösung anstelle von Triäthylamin durchgeführt werden.Yield: 132 g (92% of theory) with a melting point of 179-181 ° C., melting point: 183 - 1850C (from ethanol) The implementation can also take place in a completely analogous manner Use of an aqueous potassium carbonate solution carried out instead of triethylamine will.
Analog Beispiel A wurden folgende Verbindungen hergestellt: 2,8-Dichlor-4-thiomorpholino-pyrimidoZ5,4-dS pyrimidin Schmelzpunkt: 154-157 0C 2,8-Dichlor-4-(1-oxido-thiomorpholino)-pyrimidoZ5,4-4/pyrimidin Schmelzpunkt: 195-1980C (Dioxan) 2,8-Dichlor-4-(1,1-dioxido-thiomorpholino)-pyrimido/5,4-dUpyrimidin Schmelzpunkt: 270-2730C (Zers., Dioxan).The following compounds were prepared analogously to Example A: 2,8-dichloro-4-thiomorpholino-pyrimidoZ5,4-dS pyrimidine Melting point: 154-157 0C 2,8-dichloro-4- (1-oxido-thiomorpholino) -pyrimidoZ5,4-4 / pyrimidine Melting point: 195-1980C (dioxane) 2,8-dichloro-4- (1,1-dioxido-thiomorpholino) -pyrimido / 5,4-dupyrimidine Melting point: 270-2730C (dec., Dioxane).
Beispiel B 8-(n-Benzyl-methylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimidot5 , 4-d/pyrimidin Zu einer Suspension von 15,9 g (0,05 Mol) 2,8-Dichlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin in ca. 250 ml Dioxan wird unter Rühren eine Lösung von 12,2 g (0,1 Mol) N-Benzylmethylamin in 50 ml Dioxan langsam eingegossen und anschließend das Ganze noch etwä 30 Minuten lang auf 30-400C erwärmt. Beim Aufnehmen des Reaktionsgemisches in etwa 1 1 Wasser scheidet sich das Reaktionsprodukt als schwach gelblicher Niederschlag ab. Nach einigem Stehen wird abgesaugt, mit Wasser gewaschen und bei etwa 600C getrocknet.Example B 8- (n-Benzyl-methylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimidote 5 , 4-d / pyrimidine To a suspension of 15.9 g (0.05 mol) of 2,8-dichloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine a solution of 12.2 g (0.1 mol) of N-benzylmethylamine is added to about 250 ml of dioxane with stirring slowly poured into 50 ml of dioxane and then the whole thing for about 30 minutes warmed to 30-400C for a long time. When taking up the reaction mixture in about 1 liter of water the reaction product separates out as a pale yellowish precipitate. To Standing for some time is suctioned off, washed with water and dried at about 600C.
Ausbeute: 18,6 g (92 % -der Theorie).Yield: 18.6 g (92% of theory).
Nach Umkristallisieren aus Äthanol schmilzt das 8-(N-Benzylmethylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]-pyrimidin bei 158-160°C.After recrystallization from ethanol, the 8- (N-benzylmethylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] -pyrimidine melts at 158-160 ° C.
Analog wurden die folgenden Verbindungen hergestellt: 2-Chlor-8-diathanolamino-4-morpholino-pyrimidoL5,4-d/pyrimidin Schmelzpunkt: 129-131 0C 8-Amino-2-chlor-4-morpholino-pyrimidoL5,4-d/pyrimidin Schmelzpunkt: 206-208 0C 8-Amino-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 270-2720C (Zers.) 2-Chlor-8-methylamino-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]-pyrimidin Schmelzpunkt: 278-2800C 2-Chlor-4- (1 -oxido-thiomorpholino) -8-propylamino-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 174-176 0C 2-Chlor-8-isopropylamino-4-(1-oxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 210-212°C 8-Butylamino-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]-pyrimidin Schmelzpunkt: 179-181 0C 2-Chlor-8-isopropylamino-4-(1-oxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 176-178°C 2-Chlor-8-octylamino-4-(1-oxido-thiomorpholino)-pyrimido[5, pyrimidin Schmelzpunkt: 145-1470C 2-Chlor-8-cyclohexylamino-4-(1-oxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 207-209°C 2-Chlor-8-diathylamino-4-(1-oxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 184-1860C 2-Chlor-8-dibutylamino-4-(1-oxido-thiomorpholino)-pyrimid 4-d]pyrimidin Schmelzpukt: 187-1890C 2-Chlor-4-(1-oxido-thiomorpholino)-pyrimido-8-piperidino-pyrimido[5,4-d]-pyrimidin Schmelzpunkt: 203-2050C 2-Chlor-4-(1-oxido-thiomorpholino)-8-thiomorpholino-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 229-231°C 2-Chlor-8-morpholino-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]-pyrimidin Schmelzpunkt: 232-233 0C 8-Benzylamino-2-chlor-4-morpholino-pyrimido-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 139-141 0C 8-Benzylamino-2-chlor-4-thiomorpholino-pyrimidoL5,4-dU pyrimidin Schmelzpunkt: 94-96 0C 8-Benzylamino-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]-pyrimidin Schmelzpunkt: 232-233°C 8-Benzylamino-2-chlor-4-(1,1-dioxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 213-2150C 2-Chlor-4-morpholino-8-phenäthylamino-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 132-134 0C 2-Chlor-4- (1 -oxido-thiomorpholino) -8-phenäthylamino-pyrimido-5,4-d7pyrimidin Schmelzpunkt: 198-200°C 2-Chlor-4-(1-oxido-thiomorpholino)-8-(3-phenylpropylamino)-pyrimidor5,4-d/pyrimidin Schmelzpunkt: 152-1540C 2-Chlor-4-(1-oxido-thiomorpholino)-8-(D-1-phenylathylamino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 167-169 0C 2-Chlor-4-(1-oxido-thiomorpholino)-8-(L-1-phenyläthylamino)-pyrimidoC5 , ,4-d7pyrimidin Schmelzpunkt: 167-169 0C (N-Benzyl-methylamino)-2-chlor-4-morpholino-pyrimido[5,4-d]-pyrimidin Schmelzpunkt: 121-1230C 8- (N-Äthyl-benzylamino) -2-chlor-4- (1-oxido-thiomorpholino) -pyrimidoC5, 4-d/pyrimidin Schmelzpunkt: 163-165 0C 8-(N-Benzyl-propylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 183-184°C 8-(N-Benzyl-butylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 153-155 0C 8-Anilino-2-chlor-4-morpholino-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 193-195°C 8-Anilino-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]-pyrimidin Schmelzpunkt: 230-232°C 2-Chlor-8-(N-methylanilino)-4-morpholino-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 150-152°C 2-Chlor-8-(N-methylanilino)-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 237-239°C 2-Chlor-8-(2-hydroxyäthylamino)-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 227-229°C 2-Chlor-8-(4-hydroxybutylamino)-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 179-181°C 2-Chlor-8-diäthanolamino-4-thiomorpholino-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 121-1230C 2-Chlor-8-diäthanolamino-4-(1-oxido-thiomorpholinQ)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 187-189°C 2-Chlor-8-diisopropanolamino-4-(1-oxido-thiomorpholino)-pyrimido-5,4- S pyrimidin Schmelzpunkt: 205-2080C 2-Chlor-8-tN- (2-hydroxyäthyl) -2-methoxyäthylaminoJ-4- (i-oxidothiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 143-145°C 8-[N-Benzyl-(2-hydroxyäthylamino)]-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 153-155°C 2-Chlor-4-(1-oxido-thiomorpholino)-8-(3-picolylamino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 227-229 0C 2-Chlor-8-[N-methyl-(3-picolylamino)]-4-(1-oxido-thiomorpholino-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 154-1560C 2-Chlor-8-furfurylamino-4-(1-oxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 203-2050C 2-Chlor-8-(4-fluorbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 210-212°C 2-Chlor-8-(4-chlorbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimidoL5,4-d7pyrimidin Schmelzpunkt: 216-2180C 2-Chlor-8-(3-chlorbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 239-241°C 2-Chlor-8-(2-chlorbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 238-2400C 2-Chlor-8-(4-methylbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 185-187°C 2-Chlor-8-(3,4-dichlorbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin Schmelzpunkt: 259-261°C 2-Chlor-8-(2,4-dichlorbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimidoL5,4-d/pyrimidin Schmelzpunkt: 196-1980C 2-Chlor-8-(3,4-dimethoxylbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 218-2200C 2-Chlor-8-(3,4-methylendioxy-benzylamino)-4-(1-oxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 239-241 0C 2-Chlor-8-(3,4-dimethoxyphenäthylamino)-4-(1-oxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 214-216°C 2-Chlor-8-[N-(3,4-dimethoxyphenäthyl)-methylamino]-4-(1-oxidothiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 178-1790C 8-(4-Äthoxyanilino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 237-240°C 2-Chlor-4-(1-oxido-thiomorpholino)-8-(3-trifluormethyl-anilino)-pyrimido-[5,4-d]pyrimidin Schmelzpunkt: 215-2180C Beispiel 1 8-(N-Benzyl-methylamino)-4-(1-oxido-thiomorpholino) -2-piperaz inopyrimidot5, 4-d2pyrimidin -8,1 g (0,02 Mol) 8-(N-Benzyl-methylamino)-2-chlor-4-(1-oxidothiomorpholino)pyrimido[5,4-d]pyrimidin (Schmelzpunkt: 158 -160?C) werden mit 6,9 g (0,08 Mol) wasserfreiem Piperazin in 150 ml Dioxan etwa 30 Minuten lang unter Rückfluß erhitzt. Anschließend wird das Lösungsmittel im Vakuum abdestilliert und der verbleibende Rückstand in etwa 600 ml Wasser aufgenommen.The following compounds were prepared analogously: 2-chloro-8-diethanolamino-4-morpholino-pyrimidoL5,4-d / pyrimidine Melting point: 129-131 ° C. 8-Amino-2-chloro-4-morpholino-pyrimidoL5,4-d / pyrimidine Melting point: 206-208 0C 8-Amino-2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 270-2720C (dec.) 2-Chloro-8-methylamino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] -pyrimidine Melting point: 278-2800C 2-chloro-4- (1 -oxido-thiomorpholino) -8-propylamino-pyrimido- [5,4-d] pyrimidine Melting point: 174-176 ° C 2-chloro-8-isopropylamino-4- (1-oxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 210-212 ° C 8-Butylamino-2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] -pyrimidine Melting point: 179-181 ° C 2-chloro-8-isopropylamino-4- (1-oxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 176-178 ° C 2-chloro-8-octylamino-4- (1-oxido-thiomorpholino) -pyrimido [5, pyrimidine Melting point: 145-1470C 2-Chloro-8-cyclohexylamino-4- (1-oxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 207-209 ° C 2-Chloro-8-diethylamino-4- (1-oxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 184-1860C 2-chloro-8-dibutylamino-4- (1-oxido-thiomorpholino) -pyrimide 4-d] pyrimidine. Melting point: 187-1890C 2-Chloro-4- (1-oxido-thiomorpholino) -pyrimido-8-piperidino-pyrimido [5,4-d] -pyrimidine Melting point: 203-2050C 2-Chloro-4- (1-oxido-thiomorpholino) -8-thiomorpholino-pyrimido- [5,4-d] pyrimidine Melting point: 229-231 ° C 2-Chloro-8-morpholino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] -pyrimidine Melting point: 232-233 ° C. 8-Benzylamino-2-chloro-4-morpholino-pyrimido-pyrimido [5,4-d] pyrimidine Melting point: 139-141 ° C. 8-Benzylamino-2-chloro-4-thiomorpholino-pyrimidoL5,4-dU pyrimidine Melting point: 94-96 0C 8-Benzylamino-2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] -pyrimidine Melting point: 232-233 ° C 8-Benzylamino-2-chloro-4- (1,1-dioxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 213-2150C 2-chloro-4-morpholino-8-phenethylamino-pyrimido [5,4-d] pyrimidine Melting point: 132-134 0C 2-chloro-4- (1 -oxido-thiomorpholino) -8-phenethylamino-pyrimido-5,4-d7-pyrimidine Melting point: 198-200 ° C 2-chloro-4- (1-oxido-thiomorpholino) -8- (3-phenylpropylamino) -pyrimidor5,4-d / pyrimidine Melting point: 152-1540C 2-Chloro-4- (1-oxido-thiomorpholino) -8- (D-1-phenylethylamino) -pyrimido [5,4-d] pyrimidine Melting point: 167-169 0C 2-chloro-4- (1-oxido-thiomorpholino) -8- (L-1-phenylethylamino) -pyrimidoC5 ,, 4-d7-pyrimidine Melting point: 167-169 ° C (N-Benzyl-methylamino) -2-chloro-4-morpholino-pyrimido [5,4-d] -pyrimidine Melting point: 121-1230C 8- (N-Ethyl-benzylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimidoC5,4-d / pyrimidine Melting point: 163-165 ° C 8- (N-Benzyl-propylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 183-184 ° C 8- (N-Benzyl-butylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 153-155 ° C. 8-anilino-2-chloro-4-morpholino-pyrimido [5,4-d] pyrimidine Melting point: 193-195 ° C 8-Anilino-2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] -pyrimidine Melting point: 230-232 ° C 2-chloro-8- (N-methylanilino) -4-morpholino-pyrimido [5,4-d] pyrimidine Melting point: 150-152 ° C 2-Chloro-8- (N-methylanilino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 237-239 ° C 2-chloro-8- (2-hydroxyethylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 227-229 ° C 2-Chloro-8- (4-hydroxybutylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 179-181 ° C 2-chloro-8-diethanolamino-4-thiomorpholino-pyrimido [5,4-d] pyrimidine Melting point: 121-1230C 2-chloro-8-diethanolamino-4- (1-oxido-thiomorpholine Q) -pyrimido- [5,4-d] pyrimidine Melting point: 187-189 ° C 2-chloro-8-diisopropanolamino-4- (1-oxido-thiomorpholino) -pyrimido-5,4- S pyrimidine Melting point: 205-2080C 2-chloro-8-tN- (2-hydroxyethyl) -2-methoxyethylaminoJ-4- (i-oxidothiomorpholino) pyrimido [5,4-d] pyrimidine Melting point: 143-145 ° C 8- [N-benzyl- (2-hydroxyethylamino)] - 2-chloro-4- (1-oxido-thiomorpholino) - pyrimido [5,4-d] pyrimidine Melting point: 153-155 ° C 2-chloro-4- (1-oxido-thiomorpholino) -8- (3-picolylamino) -pyrimido- [5,4-d] pyrimidine Melting point: 227-229 ° C 2-Chloro-8- [N-methyl- (3-picolylamino)] -4- (1-oxido-thiomorpholino-pyrimido [5,4-d] pyrimidine Melting point: 154-1560C 2-Chloro-8-furfurylamino-4- (1-oxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 203-2050C 2-Chloro-8- (4-fluorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 210-212 ° C 2-chloro-8- (4-chlorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimidoL5,4-d7pyrimidine Melting point: 216-2180C 2-Chloro-8- (3-chlorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 239-241 ° C 2-Chloro-8- (2-chlorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 238-2400C 2-Chloro-8- (4-methylbenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 185-187 ° C 2-chloro-8- (3,4-dichlorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Melting point: 259-261 ° C 2-chloro-8- (2,4-dichlorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimidoL5,4-d / pyrimidine Melting point: 196-1980C 2-Chloro-8- (3,4-dimethoxylbenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 218-2200C 2-chloro-8- (3,4-methylenedioxy-benzylamino) -4- (1-oxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 239-2410C 2-chloro-8- (3,4-dimethoxyphenethylamino) -4- (1-oxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 214-216 ° C 2-chloro-8- [N- (3,4-dimethoxyphenethyl) -methylamino] -4- (1-oxidothiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 178-1790C 8- (4-Ethoxyanilino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimido- [5,4-d] pyrimidine Melting point: 237-240 ° C 2-chloro-4- (1-oxido-thiomorpholino) -8- (3-trifluoromethyl-anilino) -pyrimido- [5,4-d] pyrimidine Melting point: 215-2180C Example 1 8- (N-Benzyl-methylamino) -4- (1-oxido-thiomorpholino) -2-piperazynopyrimidot5, 4-d2pyrimidine -8.1 g (0.02 mol) of 8- (N-benzyl-methylamino) -2-chloro-4- (1-oxidothiomorpholino) pyrimido [5,4-d] pyrimidine (Melting point: 158-160 ° C.) are mixed with 6.9 g (0.08 mol) of anhydrous piperazine in Heated 150 ml of dioxane under reflux for about 30 minutes. Then the Solvent distilled off in vacuo and the remaining residue in about 600 ml of water added.
Nach kurzem Stehen wird das Reaktionsprodukt abgesaugt, mit Wasser gewaschen und bei etwa 600C getrocknet.After standing for a short time, the reaction product is filtered off with suction, with water washed and dried at about 600C.
Ausbeute: 9,1 g (95 8 der Theorie).Yield: 9.1 g (95% of theory).
Zur Reinigung wird das Rohprodukt einmal aus 0,2 n-Salzsäure mittels Ammoniak umgefällt und aus Methanol umkristallisiert.For purification, the crude product is once extracted from 0.2 N hydrochloric acid by means of Ammonia reprecipitated and recrystallized from methanol.
Das so erhaltene 8-(N-Benzyl-methylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido[5,4-d]pyrimidin schmilzt bei 114-115°C.The 8- (N-benzyl-methylamino) -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine thus obtained melts at 114-115 ° C.
C22H28N8OS (452,6) Ber.: C 58,38 H 6,24 N 24,76 S 7,08 Gef.: 58,22 6,45 24,68 7,22 Die gleiche Verbindung erhält man in analoger Weise durch zweistündiges Erhitzen von 8- (N-Benzyl-methylamino) -4- (1 -oxido-thiomorpholino)-2-phenoxy-pyrimido[5,4-d]pyrimidin (Schmelzpunkt: 187-1890C; hergestellt aus 8-(N-Benzyl-methylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimidot5,4-d7pyrimidin und Natriumphenolat in Phenol) mit Piperazin bei etwa 110°C oder durch Oxidation von 8-(N-Benzyl-methylamino)-2-piperazino-4-thiomorpholino-pyrimido[5,4-d]pyrimidin (Schmelzpunkt:108-110°C) mit Wasserstoffperoxid in Eisessig oder mit Kaliumpermanganat in verdünnter Salzsäure unter Kühlung.C22H28N8OS (452.6) Calc .: C 58.38 H 6.24 N 24.76 S 7.08 Found: 58.22 6.45 24.68 7.22 The same compound is obtained in an analogous manner by two hours Heat 8- (N-benzyl-methylamino) -4- (1 -oxido-thiomorpholino) -2-phenoxypyrimido [5,4-d] pyrimidine (Melting point: 187-1890C; prepared from 8- (N-benzyl-methylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimidot5,4-d7pyrimidine and sodium phenolate in phenol) with piperazine at about 110 ° C or by oxidation of 8- (N-Benzyl-methylamino) -2-piperazino-4-thiomorpholino-pyrimido [5,4-d] pyrimidine (Melting point: 108-110 ° C) with hydrogen peroxide in glacial acetic acid or with potassium permanganate in dilute hydrochloric acid with cooling.
Durch Umsetzen des 8-(n-Benzyl-methylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido[5,4-d]pyrimidins mit einem Überschuß der entsprechenden Säuren in Isopropanol wurden die folgenden Salze hergestellt: Schmelzpunkt des Succinats: 195-1980C, Schmelzpunkt des Maleinats: 135-138°C, Schmelzpunkt des Tartrats: 195-2000C (Zers.), Schmelzpunkt des Tosylats: 270-2730C (Zers.).By reacting the 8- (n-benzyl-methylamino) -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine with an excess of the appropriate acids in isopropanol, the following were made Salts made: Melting point of succinate: 195-1980C, melting point of maleate: 135-138 ° C, melting point of the tartrate: 195-2000C (dec.), Melting point of the tosylate: 270-2730C (dec.).
Beispiel 2 8- thanolamino-4-morpholino-2-piperazino-pyrimidoL5,4-d7pyrimidin 8,9 g (0,025 Mol) 2-Chlor-8-diäthanolamino-4-morpholino-pyrimido-[5,4-d]pyrimidin (Schmelzpunkt: 129-131 0C) werden mit 21,5 g 0 (0,25 Mol) Piperazin eine Stunde lang auf etwa 120 C erhitzt.Example 2 8-ethanolamino-4-morpholino-2-piperazino-pyrimidoL5,4-d7-pyrimidine 8.9 g (0.025 mol) of 2-chloro-8-diethanolamino-4-morpholino-pyrimido- [5,4-d] pyrimidine (Melting point: 129-131 ° C.) with 21.5 g of 0 (0.25 mol) piperazine for one hour heated to about 120 C for a long time.
Die erhaltene Schmelze wird in etwa 200 ml Wasser aufgenommen.The melt obtained is taken up in about 200 ml of water.
Nach einigem Stehen scheidet sich das Reaktionsprodukt als gelblicher Niederschlag ab. Er wird abgesaugt, mit Wasser gewaschen und bei 700C getrocknet.After standing for some time, the reaction product separates out as a yellowish color Precipitation from. It is filtered off with suction, washed with water and dried at 70.degree.
Ausbeute: 8,8 g (87 % der Theorie).Yield: 8.8 g (87% of theory).
Nach einmaligem Umfällen aus 0,1 n-Salzsäure mittels Ammoniak schmilzt das 8-Diäthanolamino-4-morpholino-2-piperazino-pyrimidot5,4-d7pyrimidin bei 188-1900C.After one reprecipitation from 0.1N hydrochloric acid using ammonia, it melts the 8-diethanolamino-4-morpholino-2-piperazino-pyrimidote5,4-d7pyrimidine at 188-1900C.
C18H28N803 (404,5) Ber.: C 53,45 H 6,98 N 27,70 Gef.: 53,20 7,03 27,40 Beispiel 3 8-Benzylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimidoß ,4- pyrimidin ~ 1,9 g (0,005 Mol) 8-Methylthio-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido[5,4-d]pyrimidin (Schmelzpunkt: 253-255°C) werden mit 25 ml Benzylamin etwa eine Stunde lang auf 150°C erhitzt. Anschließend wird das überschüssige Amin im Vakuum weitgehend abdestilliert, der verbleibende Rückstand in etwa 150 ml Wasser aufgenommen und mittels verdünnter Salzsäure auf pH 7 eingestellt. Das abgeschiedene Reaktionsprodukt wird abgesaugt, mit Wasser gewaschen und getrocknet.C18H28N803 (404.5) Calc .: C 53.45 H 6.98 N 27.70 Found: 53.20 7.03 27.40 Example 3 8-Benzylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimidoss, 4-pyrimidine ~ 1.9 g (0.005 mol) of 8-methylthio-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine (Melting point: 253-255 ° C) with 25 ml of benzylamine for about an hour Heated to 150 ° C. The excess amine is then largely distilled off in vacuo, the remaining residue taken up in about 150 ml of water and diluted using Hydrochloric acid adjusted to pH 7. The separated reaction product is suctioned off, washed with water and dried.
Ausbeute: 1,6 g (73 % der Theorie).Yield: 1.6 g (73% of theory).
Nach Umkristallisieren aus Xthanol/Wasser schmilzt das 8-Benzylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido[5,4-d]-pyrimidin bei 229-232°C.After recrystallization from ethanol / water, the 8-benzylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] -pyrimidine melts at 229-232 ° C.
C21H26N80S (438,6) Ber.: C 57,51 H 5,96 N 25,55 S 7,32 Gef.: 57,60 6,07 25,65 7,33 Beispiel 4 8-Amino-4-morpholino-2-piperazino-pyrimido[5,4-d]pyrimidin Hergestellt analog Beispiel 1 aus 8-Amino-2-chlor-4-morpholinopyrimidoL5,4-d/pyrimidin (Schmelzpunkt: 206-208°C) und Piperazin.C21H26N80S (438.6) Calcd .: C 57.51 H 5.96 N 25.55 S 7.32 Found: 57.60 6.07 25.65 7.33 Example 4 8-Amino-4-morpholino-2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 8-amino-2-chloro-4-morpholinopyrimidoL5,4-d / pyrimidine (Melting point: 206-208 ° C) and piperazine.
Schmelzpunkt: 260-263°C.Melting point: 260-263 ° C.
Beispiel 5 8-Amino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido[5,4-d]-pyrimidin Hergestellt analog Beispiel 1 aus 8-Amino-2-chlor-4-(1-oxidothiomorpholino)-pyrimido[5,4-d]pyrimidin (Schmelzpunkt: 270-2720C, Zers.) und Piperazin.Example 5 8-Amino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] -pyrimidine Prepared analogously to Example 1 from 8-amino-2-chloro-4- (1-oxidothiomorpholino) pyrimido [5,4-d] pyrimidine (Melting point: 270-2720C, dec.) And piperazine.
Schmelzpunkt: 248-25O0C (Methanol).Melting point: 248-2500C (methanol).
Beispiel 6 8-Methylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido-[5,4-d]pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-methylamino-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin (Schmelzpunkt: 278-280°C) und Piperazin in Dioxan bei 80 C.Example 6 8-Methylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido- [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8-methylamino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (Melting point: 278-280 ° C) and piperazine in dioxane at 80 C.
Schmelzpunkt: 257-2590C.Melting point: 257-2590C.
Beispiel 7 4- (1-Oxido-thiomorpholino) -2-piperazino-8-propylamino-pyrimido [5,4-d]pyrimidin Hergestellt analog Beispiel 6 aus 2-Chlor-4-(1-oxido-thiomorpholino) 8-propylamino-pyrimido/5,4-d7pyrimidin (Schmelzpunkt: 174-1760C) und Piperazin.Example 7 4- (1-Oxido-thiomorpholino) -2-piperazino-8-propylamino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 6 from 2-chloro-4- (1-oxido-thiomorpholino) 8-propylamino-pyrimido / 5,4-d7-pyrimidine (melting point: 174-1760C) and piperazine.
Schmelzpunkt: 198-2000C.Melting point: 198-2000C.
Beispiel 8 8-Isopropylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido[5,4-d]pyrimidin Hergestellt analog Beispiel 6 aus 2-Chlor-8-isoprqpylamino-4-(l-oxido-thiomorpholino) pyrimido/5,4-d7pyrimidin (Schmelzpunkt: 210-2120C) und Piperazin.Example 8 8-Isopropylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 6 from 2-chloro-8-isopropylamino-4- (l-oxido-thiomorpholino) pyrimido / 5,4-d7pyrimidine (melting point: 210-2120C) and piperazine.
Schmelzpunkt: 179-181°C (Essigsäureäthylester).Melting point: 179-181 ° C (ethyl acetate).
Beispiel 9 8-Butylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido-4-d]pyrimidin Hergestellt analog Beispiel 6 aus 8-Butylamino-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido[5,4-d]pyrimidin (Schmelzpunkt: 179-181 0C) und Piperazin.Example 9 8-Butylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido-4-d] pyrimidine Prepared analogously to Example 6 from 8-butylamino-2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (Melting point: 179-181 ° C) and piperazine.
Schmelzpunkt: 138-1400C (Dioxan).Melting point: 138-1400C (dioxane).
Beispiel 10 8-Isoamylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido-£5 , 4-d2pyrimidin Hergestellt analog Beispiel 6 aus 2-Chlor-8-isoamylamino-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 176-178°C) und Piperazin: Schmelzpunkt: 206-208°C (Methanol/Wasser).Example 10 8-Isoamylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido-£ 5 , 4-d2pyrimidine Prepared analogously to Example 6 from 2-chloro-8-isoamylamino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 176-178 ° C) and piperazine: melting point: 206-208 ° C (Methanol / water).
Beispiel 11 8-Octylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido-4-d] pyrimidin Hergestellt analog Beispiel 6 aus 2-Chlor-8-octylamino-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 145-1470C) und Piperazin.Example 11 8-Octylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido-4-d] pyrimidine Prepared analogously to Example 6 from 2-chloro-8-octylamino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 145-1470C) and piperazine.
Schmelzpunkt: 142-1440C (Essigsäureäthylester).Melting point: 142-1440C (ethyl acetate).
Beispiel 12 8-Cyclohexylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimidot5 , 4-pyrimidin Hergestellt analog Beispiel 6 aus 2-Chlor-8-cyclohexylamino-4-(1-oxido-thiomorpholino)-pyrimido g ,4-d7pyrimidin (Schmelzpunkt: 207-209°C) und Piperazin.Example 12 8-Cyclohexylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimidote 5 , 4-pyrimidine Prepared analogously to Example 6 from 2-chloro-8-cyclohexylamino-4- (1-oxido-thiomorpholino) -pyrimido g, 4-d7pyrimidine (melting point: 207-209 ° C) and piperazine.
Schmelzpunkt: 207-209°C.Melting point: 207-209 ° C.
Beispiel 13 8-Diäthylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido-[5,4-d] pyrimidin Hergestellt analog Beispiel 6 aus 2-Chlor-8-diäthylamino-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 184-1860C) und Piperazin.Example 13 8-Diethylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido- [5,4-d] pyrimidine Prepared analogously to Example 6 from 2-chloro-8-diethylamino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 184-1860C) and piperazine.
Schmelzpunkt: 185-1 870C (Essigsäureäthylester).Melting point: 185-1 870C (ethyl acetate).
Beispiel 14 8-Dibutylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimidots ,4-pyrimidin Hergestellt analog Beispiel 6 aus 2-Chlor-8-dibutylamino-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 187-1890C) und Piperazin.Example 14 8-Dibutylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimidots , 4-pyrimidine Prepared analogously to Example 6 from 2-chloro-8-dibutylamino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 187-1890C) and piperazine.
Schmelzpunkt: 171-173°C (Essigsäureäthylester).Melting point: 171-173 ° C (ethyl acetate).
Beispiel 15 4-(1-Oxido-thiomorpholino)-2-piperazino-8-piperidino-pyrimido-4-d] pyrimidin Hergestellt analog Beispiel 6 aus 2-Chlor-4-(1-oxido-thiomorpholino)-8-piperidin-pyrimido [5,4-d] (Schmelzpunkt: 203-205°C) und Piperazin.Example 15 4- (1-Oxido-thiomorpholino) -2-piperazino-8-piperidino-pyrimido-4-d] pyrimidine Prepared analogously to Example 6 from 2-chloro-4- (1-oxido-thiomorpholino) -8-piperidine-pyrimido [5.4-d] (melting point: 203-205 ° C) and piperazine.
Schmelzpunkt: 115-1170C (Essigsäureäthylester). Melting point: 115-1170C (ethyl acetate).
Beispiel 16 4-(1-Oxido-thiomorpholino)-2-piperazino-8-thiomorpholino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-4-(1-oxido-thiomorpholino)-8-thiomorpholino-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 229-231 0C) und Piperazin.Example 16 4- (1-Oxido-thiomorpholino) -2-piperazino-8-thiomorpholino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-4- (1-oxido-thiomorpholino) -8-thiomorpholino-pyrimido [5,4-d] pyrimidine (melting point: 229-231 ° C.) and piperazine.
Schmelzpunkt: 207-209 0C (Dioxan).Melting point: 207-209 ° C. (dioxane).
Beispiel 17 8-Morpholino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido-£, 4--7dpyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-morpholino-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 232-2330C) und Piperazin.Example 17 8-Morpholino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido- £, 4-7dpyrimidine Prepared analogously to Example 1 from 2-chloro-8-morpholino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 232-2330C) and piperazine.
Schmelzpunkt: 168-171 0C.Melting point: 168-171 ° C.
Beispiel 18 8-Benzylamino-4-morpholino-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8-Benzylamino-2-chlor-4-morpholino-pyrimido/5,4-b7pyrimidin (Schmelzpunkt: 139-141°C) und Piperazin.Example 18 8-Benzylamino-4-morpholino-2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 8-benzylamino-2-chloro-4-morpholino-pyrimido / 5,4-b7pyrimidine (Melting point: 139-141 ° C) and piperazine.
Schmelzpunkt: 154-1570C.Melting point: 154-1570C.
Beispiel 19 8-Benzylamino-2-piperazino-4-thiomorpholino-pyrimidin [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8-Benzylamino-2-chlor-4-thiomorpholino-pyrimido 85,4-d] pyrimidin (Schmelzpunkt: 94-96 0C) und Piperazin.Example 19 8-Benzylamino-2-piperazino-4-thiomorpholinopyrimidine [5,4-d] pyrimidine Prepared analogously to Example 1 from 8-benzylamino-2-chloro-4-thiomorpholino-pyrimido 85,4-d] pyrimidine (melting point: 94-96 0C) and piperazine.
Schmelzpunkt: 109-111 0C.Melting point: 109-111 ° C.
Beispiel 20 8-Benzylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido-5,4- pyrimidin Hergestellt analog Beispiel 1 aus 8-Benzylamino-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 232-233 0C) und Piperazin in Dioxan bei 700C.Example 20 8-Benzylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido-5,4- pyrimidine Prepared analogously to Example 1 from 8-benzylamino-2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 232-233 ° C.) and piperazine in dioxane at 70 ° C.
Schmelzpunkt: 229-232°C (Äthanol/Wasser).Melting point: 229-232 ° C (ethanol / water).
Die Substanz wird auch aus 8-Benzylamino-2-piperazino-4-thiomorpholino-pyrimido [5,4-d] pyrimidin durch Oxidation mit Natriummetaperjodat in Methanol unter Rückfluß erhalten.The substance is also made from 8-benzylamino-2-piperazino-4-thiomorpholino-pyrimido [5,4-d] pyrimidine by refluxing with sodium metaperiodate in methanol obtain.
Beispiel 21 8-Benzylamino-4-(1,1-dioxido-thiomorpholino)-2-piperazino-pyrimido85,4-ß7pyrimidin Hergestellt analog Beispiel 1 aus 8-Benzylamino-2-chlor-4-(1,1-dioxido-thiomorpholino)-pyrimidoL5,4-dg pyrimidin (Schmelzpunkt: 213-2150C) und Piperazin.Example 21 8-Benzylamino-4- (1,1-dioxido-thiomorpholino) -2-piperazino-pyrimido85,4-β7-pyrimidine Prepared analogously to Example 1 from 8-benzylamino-2-chloro-4- (1,1-dioxido-thiomorpholino) -pyrimidoL5,4-dg pyrimidine (melting point: 213-2150C) and piperazine.
Schmelzpunkt: 203-2050C.Melting point: 203-2050C.
Die Substanz wird auch aus 8-Benzylamino-4-(l-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin durch Oxidation mit Kaliumpermanganat in verdünnter Salzsäure erhalten.The substance is also made from 8-benzylamino-4- (l-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine by oxidation with potassium permanganate in dilute hydrochloric acid obtain.
Beispiel 22 4-Morpholino-8-phenäthylamino-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-4-morpholino-8-phenäthylamino-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 132-134°C) und Piperazin.Example 22 4-Morpholino-8-phenethylamino-2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-4-morpholino-8-phenethylamino-pyrimido [5,4-d] pyrimidine (melting point: 132-134 ° C) and piperazine.
Schmelzpunkt: 125-1270C (Cyclohexan).Melting point: 125-1270C (cyclohexane).
Beispiel 23 4-(1-Oxido-thiomorpholino)-8-phenäthylamino-2-piperazino-pyrimidoJ, 4-'d/pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-4-(1-oxido-thiomorpholino)-8-phenäthylamino-pyrimido [5,4-d] pyrimidin (Schmelpunkt: 198-200°C) und Piperazin.Example 23 4- (1-Oxido-thiomorpholino) -8-phenethylamino-2-piperazino-pyrimidoJ, 4-'d / pyrimidine Prepared analogously to Example 1 from 2-chloro-4- (1-oxido-thiomorpholino) -8-phenethylamino-pyrimido [5,4-d] pyrimidine (melting point: 198-200 ° C) and piperazine.
Schmelzpunkt: 213-215°C (Methanol).Melting point: 213-215 ° C (methanol).
Beispiel 24 4-(1-Oxido-thiomorpholino)-8-(3-phenylpropylamino)-2-piperazinopyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-4-(1-oxido-thiomorpholino)-8-(3-phenylpropylamino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 152-1540C) und Piperazin.Example 24 4- (1-Oxido-thiomorpholino) -8- (3-phenylpropylamino) -2-piperazinopyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-4- (1-oxido-thiomorpholino) -8- (3-phenylpropylamino) -pyrimido [5,4-d] pyrimidine (melting point: 152-1540C) and piperazine.
Schmelzpunkt: 210-2120C (Methanol).Melting point: 210-2120C (methanol).
Beispiel 25 4-(1-Oxido-thiomorpholino)-8-(D-1-phenyläthylamino)-2-piperazinopyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-4-(1-oxido-thiomorpholino)-8-(D-1-phenyläthylamino)-pyrimido 85,4-d] pyrimidin (Schmelzpunkt: 167-1690C) und Piperazin.Example 25 4- (1-Oxido-thiomorpholino) -8- (D-1-phenylethylamino) -2-piperazinopyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-4- (1-oxido-thiomorpholino) -8- (D-1-phenylethylamino) -pyrimido 85,4-d] pyrimidine (melting point: 167-1690C) and piperazine.
Schmelzpunkt: 115-1200C.Melting point: 115-1200C.
Beispiel 26 4-(1-Oxido-thiomorpholino)-8-(L-1-phenyläthylamino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-4-(1-oxido-thiomorpholino)-8-(L-1-phenyläthylamino)-pyrimido 85,4-d9 pyrimidin (Schmelzpunkt: 167-1690C) und Piperazin.Example 26 4- (1-Oxido-thiomorpholino) -8- (L-1-phenylethylamino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-4- (1-oxido-thiomorpholino) -8- (L-1-phenylethylamino) -pyrimido 85,4-d9 pyrimidine (melting point: 167-1690C) and piperazine.
Schmelzpunkt: 115-1200C.Melting point: 115-1200C.
Beispiel 27 8- (N-Benzyl-methylamino) -4-morpholino-2-piperazino-pyrimidojs, 4-d7pyrimidin Hergestellt analog Beispiel 1 aus 8-(N-Benzyl-methylamino)-2-chlor-4-morpholino-pyrimido [5,4-d9 pyrimidin (Schmelzpunkt: 121-1230C) und Piperazin.Example 27 8- (N-Benzyl-methylamino) -4-morpholino-2-piperazino-pyrimidojs, 4-d7pyrimidine Prepared analogously to Example 1 from 8- (N-benzyl-methylamino) -2-chloro-4-morpholino-pyrimido [5,4-d9 pyrimidine (melting point: 121-1230C) and piperazine.
Schmelzpunkt: 147-1490C.Melting point: 147-1490C.
Beispiel 28 8-(N-Benzyl-methylamino)-2-piperazino-4-thiomorpholino-pyrimidots, 4-4ipyrimidin Hergestellt analog Beispiel 1 aus 8-(N-Benzyl-methylamino)-2-chlor-4-thiomorpholino-pyrimido/5,4-d7pyrimidin und Piperazin.Example 28 8- (N-Benzyl-methylamino) -2-piperazino-4-thiomorpholino-pyrimidots, 4-4ipyrimidine Prepared analogously to Example 1 from 8- (N-benzyl-methylamino) -2-chloro-4-thiomorpholino-pyrimido / 5,4-d7-pyrimidine and piperazine.
Schmelzpunkt: 108-1100C (Methanol).Melting point: 108-1100C (methanol).
Beispiel 29 8-(N-Äthyl-benzylamino)-4-(1-oxido-thiomorpholino)-2-piperazinopyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8-(N-Äthyl-benzylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido 5,4-4Jpyrimidín (Schmelzpunkt: 163-165°C) und Piperazin.Example 29 8- (N-Ethyl-benzylamino) -4- (1-oxido-thiomorpholino) -2-piperazinopyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 8- (N-ethylbenzylamino) -2-chloro-4- (1-oxido-thiomorpholino) pyrimido 5,4-4Jpyrimidín (melting point: 163-165 ° C) and piperazine.
Schmelzpunkt: 174-176°C (Methanol/Wasser).Melting point: 174-176 ° C (methanol / water).
Beispiel 30 8-(N-Benzyl-propylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8-(N-Benzyl-propylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido/5,4-d/pyrimidin (Schmelzpunkt: 183-184°C) und Piperazin.Example 30 8- (N-Benzyl-propylamino) -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 8- (N-benzyl-propylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimido / 5,4-d / pyrimidine (Melting point: 183-184 ° C) and piperazine.
Schmelzpunkt: 158-160°C (Methanol/Wasser).Melting point: 158-160 ° C (methanol / water).
Beispiel 31 8-(N-Benzyl-butylamino)-4-(1-oxido-thimorpholino)-2-piperazinopyrimidot5, 4-Jdpyrimidin Hergestellt analog Beispiel 1 aus 8-(N-Benzyl-butylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimidog5,4-d7pyrimidin (Schmelzpunkt: 153-1550C) und Piperazin.Example 31 8- (N-Benzyl-butylamino) -4- (1-oxido-thimorpholino) -2-piperazinopyrimidot5, 4-Idpyrimidine Prepared analogously to Example 1 from 8- (N-benzyl-butylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimidog5,4-d7pyrimidine (Melting point: 153-1550C) and piperazine.
Schmelzpunkt: 154-156°C.Melting point: 154-156 ° C.
Beispiel 32 8-Anilino-4-morpholino-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8-Anilino-2-chlor-4-morpholinopyrimidoC5 4-d7pyrimidin (Schmelzpunkt: 193-195°C) und Piperazin.Example 32 8-Anilino-4-morpholino-2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 8-anilino-2-chloro-4-morpholinopyrimidoC5 4-d7pyrimidine (Melting point: 193-195 ° C) and piperazine.
Schmelzpunkt: 184-1860C (Methanol).Melting point: 184-1860C (methanol).
Beispiel 33 8-Anilino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido-[5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8-Anilino-2-chlor-4-(1-oxidothiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 230 -232°C) und Piperazin.Example 33 8-Anilino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido- [5,4-d] pyrimidine Prepared analogously to Example 1 from 8-anilino-2-chloro-4- (1-oxidothiomorpholino) pyrimido [5,4-d] pyrimidine (melting point: 230-232 ° C) and piperazine.
Schmelzpunkt: 208-210°C (Äthanol).Melting point: 208-210 ° C (ethanol).
Beispiel 34 8-(N-Methylanilino)-4-morpholino-2-piperazino-pyrimido [5,4-d]-pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-(N-methylanilino)- 4-morpholino-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 150-152°C) und Piperazin.Example 34 8- (N-Methylanilino) -4-morpholino-2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8- (N-methylanilino) - 4-morpholino-pyrimido [5,4-d] pyrimidine (melting point: 150-152 ° C) and piperazine.
Schmelzpunkt: 212-215°C.Melting point: 212-215 ° C.
Beispiel 35 8-(N-Methylanilino)-4-(1-oxido-thiomorpholino)-2-piperazinopyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-(N-methylanilino)-4-(1-oxido-thiomorpholino)-pyrimido g ,4-d7pyrimidin (Schmelzpunkt: 237-239°C) und Piperazin.Example 35 8- (N-Methylanilino) -4- (1-oxido-thiomorpholino) -2-piperazinopyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8- (N-methylanilino) -4- (1-oxido-thiomorpholino) -pyrimido g, 4-d7pyrimidine (melting point: 237-239 ° C) and piperazine.
Schmelzpunkt: 257-259 0C (Dioxan).Melting point: 257-259 0C (dioxane).
Beispiel 36 8-(2-Hydroxyäthylamino)-4-(1-oxido-thiomorpholino)-2-piperazinopyrimidoJ , 4-/pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-(2-hydroxyäthylamino)-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 227-229°C) und Piperazin.Example 36 8- (2-Hydroxyethylamino) -4- (1-oxido-thiomorpholino) -2-piperazinopyrimidoJ , 4- / pyrimidine Prepared analogously to Example 1 from 2-chloro-8- (2-hydroxyethylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 227-229 ° C) and piperazine.
Schmelzpunkt: 228-230°C (Äthanol).Melting point: 228-230 ° C (ethanol).
Beispiel 37 8-(4-Hydroxyäthylamino)-4-(1-oxido-thiomorpholino)-2-piperazinopyrimido£5, 4-pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-(4-hydroxybutylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-(Schmelzpunkt: 179-181 0C) und Piperazin.Example 37 8- (4-Hydroxyäthylamino) -4- (1-oxido-thiomorpholino) -2-piperazinopyrimido £ 5, 4-pyrimidine Prepared analogously to Example 1 from 2-chloro-8- (4-hydroxybutylamino) -4- (1-oxido-thiomorpholino) -2-piperazino- (melting point: 179-181 ° C) and piperazine.
Schmelzpunkt: 187-189°C (Äthanol/Essigsäureäthylester).Melting point: 187-189 ° C (ethanol / ethyl acetate).
Beispiel 38 8-Diäthanolamino-2-piperazino-4-thiomorpholino-pyrimido [5,4-d]-pyrimidin Hergestellt analog Beispiel 2 aus 2-Chlor-8-diäthanolamino-4-thiomorpholino-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 121-123°C) und Piperazin.Example 38 8-Diethanolamino-2-piperazino-4-thiomorpholino-pyrimido [5,4-d] -pyrimidine Prepared analogously to Example 2 from 2-chloro-8-diethanolamino-4-thiomorpholino-pyrimido [5,4-d] pyrimidine (melting point: 121-123 ° C) and piperazine.
Schmelzpunkt: 192-1950C.Melting point: 192-1950C.
Beispiel 39 8-Diäthanolamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido-[5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-diäthanolamino-4-(1-oxido-thiomorpholino)-pyrimido g5,4-d/pyrimidin (Schmelzpunkt: 187-189°C) und Piperazin.Example 39 8-Diethanolamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido- [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8-diethanolamino-4- (1-oxido-thiomorpholino) -pyrimido g5,4-d / pyrimidine (melting point: 187-189 ° C) and piperazine.
Schmelzpunkt: 226-228°C (Äthanol).Melting point: 226-228 ° C (ethanol).
Beispiel 40 8-Diisopropanolamino-4-(1-oxido-thiomorpholino)-2-piperazinopyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-diisopropanolamino-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 205-208°C) und Piperazin.Example 40 8-Diisopropanolamino-4- (1-oxido-thiomorpholino) -2-piperazinopyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8-diisopropanolamino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 205-208 ° C) and piperazine.
Schmelzpunkt: 222-225°C (Äthanol).Melting point: 222-225 ° C (ethanol).
Beispiel 41 8-EN- (2-Hydroxyäthyl) -2-methoxyäthylaminJ/-4- (1 -oxido-thiomorpholino)-2-piperazino-pyrimido 85,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-£N-(2-hydroxyäthyl)-2-methoxyäthylamino]-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d]-pyrimidin (Schmelzpunkt: 143-1450C) und Piperazin.Example 41 8-EN- (2-hydroxyethyl) -2-methoxyethylamineJ / -4- (1 -oxido-thiomorpholino) -2-piperazino-pyrimido 85,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8- £ N- (2-hydroxyethyl) -2-methoxyethylamino] -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 143-1450C) and piperazine.
Schmelzpunkt: 143-1460C (Essigsäureäthylester).Melting point: 143-1460C (ethyl acetate).
Beispiel 42 8-[N-Benzyl-(2-hydroxyäthylamino)]-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimidoC5,4-g7pyrimidin Hergestellt analog Beispiel 1 aus 8-/N-Benzyl-(2-hydroxyäthylamino]-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 153-1550C) und Piperazin.Example 42 8- [N-Benzyl- (2-hydroxyethylamino)] - 4- (1-oxido-thiomorpholino) -2-piperazino-pyrimidoC5,4-g7-pyrimidine Prepared analogously to Example 1 from 8- / N-benzyl- (2-hydroxyethylamino] -2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 153-1550C) and piperazine.
Schmelzpunkt: 138-141 0C.Melting point: 138-141 ° C.
Beispiel 43 4-(1-Oxido-thiomorpholino)-8-(3-picolylamino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-4-(1-oxido-thiomorpholino)-8-(3-picolylamino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 227-229°C) und Piperazin.Example 43 4- (1-Oxido-thiomorpholino) -8- (3-picolylamino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-4- (1-oxido-thiomorpholino) -8- (3-picolylamino) -pyrimido [5,4-d] pyrimidine (melting point: 227-229 ° C) and piperazine.
Schmelzpunkt: 267-2690C.Melting point: 267-2690C.
Beispiel 44 8 Methyl-(3-picolylamino)/-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-[N-methyl-(3-picolylamino)]-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 154-156°C) und Piperazin.Example 44 8 Methyl- (3-picolylamino) / - 4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8- [N-methyl- (3-picolylamino)] - 4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 154-156 ° C) and piperazine.
Schmelzpunkt: 191-194°C (Methanol).Melting point: 191-194 ° C (methanol).
Beispiel 45 8-Furfurylamino-4- (1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-furfurylamino-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 203-205°C) und Piperazin in Dioxan bei 800C.Example 45 8-Furfurylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8-furfurylamino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 203-205 ° C) and piperazine in dioxane at 80 ° C.
Schmelzpunkt: 219-221 0C.Melting point: 219-221 ° C.
Beispiel 46 8-Benzylamino-2-(N-methylpiperazino)-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8-Benzylamino-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 232-233°C) und N-Methylpiperazin.Example 46 8-Benzylamino-2- (N-methylpiperazino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 8-benzylamino-2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 232-233 ° C) and N-methylpiperazine.
Schmelzpunkt: 203-205°C (Äthanol).Melting point: 203-205 ° C (ethanol).
Beispiel 47 8-Benzylamino-2-(N-hydroxyäthylpiperazino)-4-morpholino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8-Benzylamino-2-chlor-4-morpholino-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 139-141 0C) und N-Hydroxyäthylpiperazin in Dioxan bei 70 C.Example 47 8-Benzylamino-2- (N-hydroxyethylpiperazino) -4-morpholino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 8-benzylamino-2-chloro-4-morpholino-pyrimido [5,4-d] pyrimidine (melting point: 139-141 ° C.) and N-hydroxyethylpiperazine in dioxane at 70 C.
Schmelzpunkt: 161-1 630C (Cyclohexan/Essigsäureäthylester).Melting point: 161-1 630C (cyclohexane / ethyl acetate).
Beispiel 48 8-Benzylamino-2-(N-hydroxyäthylpiperazino)-4-(1-oxido-thimorpholino)-pyrimidoL5,4-Dpyrimidin ergestellt analog Beispiel 1 aus 8-Benzylamino-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 232-233 0C) und N-Hydroxyäthylpiperazin.Example 48 8-Benzylamino-2- (N-hydroxyethylpiperazino) -4- (1-oxido-thimorpholino) -pyrimidoL5,4-D-pyrimidine prepared analogously to Example 1 from 8-benzylamino-2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 232-233 ° C.) and N-hydroxyethylpiperazine.
Schmelzpunkt: 184-186°C (Äthanol).Melting point: 184-186 ° C (ethanol).
Beispiel 49 8-(N-Benzyl-methylamino)-2-(N-hydroxyäthylpiperazino)-4-(1-oxidothiomorpholino)-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8-(N-Benzyl-methylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimidoL5,4- S pyrimidin (Schmelzpunkt: 158-160°C) und N-Hydroxyäthylpiperazin.Example 49 8- (N-Benzyl-methylamino) -2- (N-hydroxyethylpiperazino) -4- (1-oxidothiomorpholino) pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 8- (N-benzyl-methylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimidoL5,4- S pyrimidine (melting point: 158-160 ° C) and N-hydroxyethylpiperazine.
Schmelzpunkt: 126-13O0C (Essigsäureäthylester).Melting point: 126-130 ° C. (ethyl acetate).
Beispiel 50 2-(N-ydroxyäthylpiperazino)-4-(1-oxido-thiomorpholino)-8-phenäthylamino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-4-(l-oxido-thiomorpholino)-8-phenäthylamino-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 198-2000C) und N-Hydroxyäthylpiperazin.Example 50 2- (N-hydroxyethylpiperazino) -4- (1-oxido-thiomorpholino) -8-phenethylamino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-4- (1-oxido-thiomorpholino) -8-phenethylamino-pyrimido [5,4-d] pyrimidine (melting point: 198-2000C) and N-hydroxyethylpiperazine.
Schmelzpunkt: 166-1680C (Essigsäureäthylester).Melting point: 166-1680C (ethyl acetate).
Beispiel 51 8-(4-Fluorobenzylamino)-4-(1-oxido-thiomorpholino)-2-piperazinopyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-(4-fluorbenzylamino) -4(1 -oxido-thiomorpholino) -pyrimidoJ5,4-dJpyrimidin (Schmelzpunkt: 210-2120C) und Piperazin in Dioxan bei 800C.Example 51 8- (4-Fluorobenzylamino) -4- (1-oxido-thiomorpholino) -2-piperazinopyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8- (4-fluorobenzylamino) -4 (1 -oxido-thiomorpholino) -pyrimidoJ5,4-dJpyrimidine (melting point: 210-2120C) and piperazine in dioxane at 800C.
Schmelzpunkt: 148-t5000.Melting point: 148-t5000.
Beispiel 52 8-(4-Clorobenzylamino)-4-(1-oxido-thiomorpholino)-2-piperazinopyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 51 aus 2-Chlor-8-(4-chlorbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido/5,4-d/pyrimidin (Schmelzpunkt: 216-2180C) und Piperazin.Example 52 8- (4-Chlorobenzylamino) -4- (1-oxido-thiomorpholino) -2-piperazinopyrimido [5,4-d] pyrimidine Prepared analogously to Example 51 from 2-chloro-8- (4-chlorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido / 5,4-d / pyrimidine (Melting point: 216-2180C) and piperazine.
Schmelzpunkt: 227-229°C (Dioxan).Melting point: 227-229 ° C (dioxane).
Beispiel 53 8-(3-Chlorobenzylamino)-4-(1-oxido-thimorpholino)-2-piperazinopyrimido£5 , 4-p7pyrimidin Hergestellt analog Beispiel 51 aus 2-Chlor-8-(3-chlorbenzylamino) -4- (1-oxido-thiomorpholino) -pyrimidoE5, 4-dpyrimidin (Schmelzpunkt: 239-241 0C) und Piperazin.Example 53 8- (3-Chlorobenzylamino) -4- (1-oxido-thimorpholino) -2-piperazinopyrimido £ 5 , 4-p7pyrimidine Prepared analogously to Example 51 from 2-chloro-8- (3-chlorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimidoE5, 4-dpyrimidine (melting point: 239-241 0C) and piperazine.
Schmelzpunkt: 208-2180C (Dioxan).Melting point: 208-2180C (dioxane).
Beispiel 54 8-(2-Chlorobenzylamino)-4-(1-oxido-thiomorpholino)-2-piperazinopyrimido, 4-pyrimidin Hergestellt analog Beispiel 51 aus 2-Chlor-8-(2-Chlo5robenzylamino) -4- (1-oxido-thiomorpholino) pyrimidot5 , 4-djpyrimidin (Schmelzpunkt: 238-24O0C) und Piperazin.Example 54 8- (2-Chlorobenzylamino) -4- (1-oxido-thiomorpholino) -2-piperazinopyrimido, 4-pyrimidine Prepared analogously to Example 51 from 2-chloro-8- (2-Chlo5robenzylamino) -4- (1-oxido-thiomorpholino) pyrimidot5, 4-djpyrimidine (melting point: 238-2400C) and piperazine.
Schmelzpunkt: 193-1950C (Dioxan).Melting point: 193-1950C (dioxane).
Beispiel 55 8-(4-Methylbenzylamino)-4-(1-oxido-thiomorpholino)-2-piperazinopyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 51 aus 2-Chlor-8-(4-methylbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 185-1870C) und Piperazin.Example 55 8- (4-Methylbenzylamino) -4- (1-oxido-thiomorpholino) -2-piperazinopyrimido [5,4-d] pyrimidine Prepared analogously to Example 51 from 2-chloro-8- (4-methylbenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 185-1870C) and piperazine.
Schmelzpunkt: 172-1740C (Methanol).Melting point: 172-1740C (methanol).
Beispiel 56 8-(3,4-Dichlorobenzylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 51 aus 2-Chlor-8-(3,4-dichlorbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 259-261 0C) und Piperazin. Example 56 8- (3,4-Dichlorobenzylamino) -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 51 from 2-chloro-8- (3,4-dichlorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 259-261 ° C.) and piperazine.
Schmelzpunkt: 201-2030C. Melting point: 201-2030C.
Beispiel 57 8-(2,4-Dichlorobenzylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 51 aus 2-Chlor-8-(2,4-dichlorbenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 196-198°C) und Piperazin. Example 57 8- (2,4-Dichlorobenzylamino) -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 51 from 2-chloro-8- (2,4-dichlorobenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 196-198 ° C) and piperazine.
-Schmelzpunkt: 235-237 0C (Dioxan).-Melting point: 235-237 0C (dioxane).
Beispiel 58 8-(3,4-Dimethoxybenzylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 51 aus 2-Chlor-8-(3,4-dimethoxybenzylamino)-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 218-2200C) und Piperazin. Example 58 8- (3,4-Dimethoxybenzylamino) -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 51 from 2-chloro-8- (3,4-dimethoxybenzylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 218-2200C) and piperazine.
Schmelzpunkt: 198-2000C (Dioxan). Melting point: 198-2000C (dioxane).
Beispiel 59 8-(3,4-Dichlorobenzylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 51 aus 2-Chlor-8-(3,4-methylendioxybenzylamino)-4-(1-oxido-thiomorpholino)-pyrimidoZ5,4-d/pyrimidin (Schmelzpunkt: 239-241 0C) und Piperazin.Example 59 8- (3,4-Dichlorobenzylamino) -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 51 from 2-chloro-8- (3,4-methylenedioxybenzylamino) -4- (1-oxido-thiomorpholino) -pyrimidoZ5,4-d / pyrimidine (Melting point: 239-2410C) and piperazine.
Schmelzpunkt: 233-2350C (Essigsäureäthylester/Dioxan).Melting point: 233-2350C (ethyl acetate / dioxane).
Beispiel 60 8-(3,4-Dichlorobenzylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-(3,4-dimethoxyphenäthylamino)-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 214-216°C) und Piperazin.Example 60 8- (3,4-Dichlorobenzylamino) -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8- (3,4-dimethoxyphenethylamino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 214-216 ° C) and piperazine.
Schmelzpunkt: 166-167°C (Methanol).Melting point: 166-167 ° C (methanol).
Beispiel 61 8-[N-(3,4-Dimethoxyphenäthyl)-methylamino]-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-8-LN-(3,4-dimethoxyphenäthyl)-methylamino]-4-(1-oxido-thiomorpholino)-pyrimido-5 ,4-d/pyrimidin (Schmelzpunkt: 178-179°C) und Piperazin.Example 61 8- [N- (3,4-Dimethoxyphenethyl) methylamino] -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-8-LN- (3,4-dimethoxyphenethyl) methylamino] -4- (1-oxido-thiomorpholino) -pyrimido-5 , 4-d / pyrimidine (melting point: 178-179 ° C) and piperazine.
Schmelzpunkt: 145-147°C (Essigsäureäthylester).Melting point: 145-147 ° C (ethyl acetate).
Beispiel 62 8-(4-Äthoxyanilino)-4-(1-oxido-thiomorpholino)-2-piperazino pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 8- (4-Äthoxyanilino) -2-chlor-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 237-24O0C) und Piperazin.Example 62 8- (4-Ethoxyanilino) -4- (1-oxido-thiomorpholino) -2-piperazino pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 8- (4-ethoxyanilino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 237-2400C) and piperazine.
Schmelz: 215-217°C (Äthanol).Melting point: 215-217 ° C (ethanol).
Beispiel 63 4-(1-Oxido-thiomorpholino)-2-piperazino-8-(3-trifluormethylanilino)-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 1 aus 2-Chlor-4-(1-oxido-thiomorpholino)-8-(3-trifluormethyl-anilino)-pyrimido/5,4-dSpyrimidin (Schmelzpunkt: 215-2180C) und Piperazin.Example 63 4- (1-Oxido-thiomorpholino) -2-piperazino-8- (3-trifluoromethylanilino) -pyrimido [5,4-d] pyrimidine Prepared analogously to Example 1 from 2-chloro-4- (1-oxido-thiomorpholino) -8- (3-trifluoromethyl-anilino) -pyrimido / 5,4-d-pyrimidine (Melting point: 215-2180C) and piperazine.
Schmelzpunkt: 263-2660C (Dioxan).Melting point: 263-2660C (dioxane).
Beispiel 64 2-(N-Formylpiperazino)-8-morpholino-4-(1-oxido-thiomorpholino)-pyflmidoE5, 4-d2pyrimidin Hergestellt analog Beispiel 2 aus 2-Chlor-8-morpholino-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt): 232-2330C) und'N-Formylpiperazin bei 1000C.Example 64 2- (N-Formylpiperazino) -8-morpholino-4- (1-oxido-thiomorpholino) -pyflmidoE5, 4-d2pyrimidine Prepared analogously to Example 2 from 2-chloro-8-morpholino-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 232-2330C) and'N-formylpiperazine at 1000C.
Schmelzpunkt: 189-191°C (Methanol/Wasser).Melting point: 189-191 ° C (methanol / water).
Beispiel 65 8-Amino-2-(N-formylpiperazino)-4-(1-oxido-thiomorpholino)-pyrimidot5, 4-Wpyrimidin Hergestellt analog Beispiel 64 aus 8-Amino-2-chlor-4-(1-oxidothiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 270-2720C, Zers.) und N-Formylpiperazin bei 1300C.Example 65 8-Amino-2- (N-formylpiperazino) -4- (1-oxido-thiomorpholino) -pyrimidot5, 4-Wpyrimidine Prepared analogously to Example 64 from 8-amino-2-chloro-4- (1-oxidothiomorpholino) pyrimido [5,4-d] pyrimidine (melting point: 270-2720C, dec.) And N-formylpiperazine at 1300C.
Schmelzpunkt: 278-2800C.Melting point: 278-2800C.
Beispiel 66 8-Benzylamino-2-(N-formylpiperazino)-4-thiomorpholino-pyrimido-[5,4-d] pyrimidin-Hergestellt analog Beispiel 64 aus 8-Benzylamino-2-chlor-4-thiomorpholino-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 94-96 0C) und N-Formylpiperaz in.Example 66 8-Benzylamino-2- (N-formylpiperazino) -4-thiomorpholino-pyrimido- [5,4-d] pyrimidine prepared analogously to Example 64 from 8-benzylamino-2-chloro-4-thiomorpholino-pyrimido [5,4-d] pyrimidine (melting point: 94-96 ° C.) and N-formylpiperaz in.
Schmelzpunkt: 187-189°C.Melting point: 187-189 ° C.
Beispiel 67 8-Benzylamino-2-(N-formylpiperazino)-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 64 aus 8-Benzylamino-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 232-233°C) und N-Formylpiperazin.Example 67 8-Benzylamino-2- (N-formylpiperazino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine Prepared analogously to Example 64 from 8-benzylamino-2-chloro-4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 232-233 ° C) and N-formylpiperazine.
Schmelzpunkt: 152-1550C (Sthanol/Wasser).Melting point: 152-1550C (ethanol / water).
Die Substanz wird auch aus 8-Amino-2-(N-formylpiperazino)-4-(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin durch Umsetzung mit Benzylchlorid und Kalium-tert. butylat in Dimethylsulfoxid erhalten.The substance is also made from 8-amino-2- (N-formylpiperazino) -4- (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine by reaction with benzyl chloride and potassium tert. butylate in Obtained dimethyl sulfoxide.
Beispiel 68 8-(N-Benzyl-methylamino)-2-(N-formylpiperazino)-4-(1-oxido-thiomorpholino-pyrimido [5,4-d] pyrimidin Hergestellt analog Beispiel 64 aus 8-(N-Benzyl-methylamino)-2-chlor-4-(1-oxido-thiomorpholino)-pyrimido5,4-Spyrimidin (Schmelzpunkt: 158-1600C) und N-Formylpiperazin.Example 68 8- (N-Benzyl-methylamino) -2- (N-formylpiperazino) -4- (1-oxido-thiomorpholino-pyrimido [5,4-d] pyrimidine Prepared analogously to Example 64 from 8- (N-benzyl-methylamino) -2-chloro-4- (1-oxido-thiomorpholino) -pyrimido5,4-pyrimidine (Melting point: 158-1600C) and N-formylpiperazine.
Schmelzpunkt: 135-1370C (Methanol).Melting point: 135-1370C (methanol).
Die Substanz wird auch aus dem 8-(N-Benzyl-methylamino)-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimidog,4-d7pyrimidin (Schmelzpunkt: 114-1150C) durch Erhitzen mit Chloralhydrat in Chloroform unter Rückfluß erhalten.The substance is also made from 8- (N-benzyl-methylamino) -4- (1-oxido-thiomorpholino) -2-piperazino-pyrimidog, 4-d7pyrimidine (Melting point: 114-1150C) by refluxing with chloral hydrate in chloroform obtain.
Beispiel 69 2-(N-Formylpiperazino)-4- (1-oxido-thiomorpholino)-8-phenäthylamino-pyrimidot5 , 4-d2pyrimidin Hergestellt analog Beispiel 64 aus 2-Chlor-4-(1-oxido-thiomorpholino)-8-phenäthylamino-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 198-2000C) und N-Formylpiperazin.Example 69 2- (N-Formylpiperazino) -4- (1-oxido-thiomorpholino) -8-phenethylamino-pyrimidot5 , 4-d2pyrimidine Prepared analogously to Example 64 from 2-chloro-4- (1-oxido-thiomorpholino) -8-phenethylamino-pyrimido [5,4-d] pyrimidine (melting point: 198-2000C) and N-formylpiperazine.
Schmelzpunkt: 204-207 0C.Melting point: 204-207 ° C.
Beispiel 70 2-Piperazino-4,8-bis(1-oxido-thiomorpholino) -pyrimido/5,4-d/-pyrimidin.Example 70 2-Piperazino-4,8-bis (1-oxido-thiomorpholino) -pyrimido / 5,4-d / -pyrimidine.
Hergestellt analog Beispiel 1 aus 2-Chlor-4,8-bis(1-oxido-thiomorpholino)-pyrimido [5,4-d] pyrimidin (Schmelzpunkt: 295-297°C) und Piperazin.Prepared analogously to Example 1 from 2-chloro-4,8-bis (1-oxido-thiomorpholino) -pyrimido [5,4-d] pyrimidine (melting point: 295-297 ° C) and piperazine.
Schmelzpunkt: 251-2530C.Melting point: 251-2530C.
Beispiel A Dragees mit 1 mg 8-Benzylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin Zusammensetzung: 1 Dragéekern enthält: Wirksubstanz (1) 1,0 mg Milchzucker (2) 30,0 mg Maisstärke (3) 14,5 mg Polyvinylpyrrolidon (4) 4,0 mg Magnesiumstearat (5) 0,5 mg 50,0 mg Herstellung: Die Stoffe 1-3 werden mit einer wäßrigen Lösung von 4 gleichmäßig befeuchtet, durch 1 mm-Maschenweite gesiebt, getrocknet und erneut durch 1 mm-Maschenweite gesiebt. Nach Zumischen von 5 5 wird die Mischung zu Dragéekernen verpreßt.Example A Dragees with 1 mg of 8-benzylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine Composition: 1 tablet core contains: Active ingredient (1) 1.0 mg Milk sugar (2) 30.0 mg corn starch (3) 14.5 mg polyvinylpyrrolidone (4) 4.0 mg magnesium stearate (5) 0.5 mg 50.0 mg Preparation: Substances 1-3 are mixed with an aqueous solution evenly moistened by 4, sieved through 1 mm mesh size, dried and again sieved through 1 mm mesh size. After adding 5 5, the mixture becomes tablet cores pressed.
Drageekerne: 5 mm , bikonvex, rund Dragierunq: Übliche Zuckerdragierung auf 70 mg Endgewicht. Dragee cores: 5 mm, biconvex, round. Dragee: Usual sugar coating to 70 mg final weight.
Beispiel B Tabletten mit 2 mg 8-Benzylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido [5,4-d] pyrimidin 1 Tablette enthält: Wirksubstanz 2,0 mg Milchzucker 29,0 mg Maisstärke 14,5 mg Polyvinylpyrrolidon 4,0 mg Magnesiumstearat 0,5 mg 50,0 mg Herstellung: Analog den Dragéekernen Tablettenbeschreibung: Gewicht: 50 mg Durchmesser: 5 mm, biplan, beidseitige Facette Beispiel C Suppositorien zu 5 mg 8-Benzylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidin 1 Zäpfchen enthält: Wirksubstanz 0,005 g Hartfett (z.B. Witepsol H 19 1,695 g und Witepsol W 45 ~~~~~~~~ 1,700 g Herstellung: Das Hartfett wird geschmolzen. Bei 380C wird die gemahlene Wirksubstanz in der Schmelze homogen dispergiert. Es wird auf 350C abgekühlt und in schwach vorgekühlte Suppositorienformen ausgegossen.Example B Tablets containing 2 mg of 8-benzylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine 1 tablet contains: Active ingredient 2.0 mg lactose 29.0 mg corn starch 14.5 mg polyvinylpyrrolidone 4.0 mg magnesium stearate 0.5 mg 50.0 mg Manufacturing: Analogous to the dragee cores, tablet description: Weight: 50 mg Diameter: 5 mm, biplan, double-sided facet Example C suppositories of 5 mg 8-benzylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido [5,4-d] pyrimidine 1 suppository contains: active substance 0.005 g hard fat (e.g. Witepsol H 19 1.695 g and Witepsol W 45 ~~~~~~~~ 1.700 g Preparation: The hard fat is melted. At 380C the milled active substance becomes in the melt homogeneously dispersed. It is cooled to 350C and placed in slightly pre-chilled suppository molds poured out.
Zäpfchengewicht: 1,7 g Beispiel D Suspension mit 2 mg 8-Benzylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimido/3,4-d7pyrimidin 100 ml Suspension enthalten: Wirksubstanz 0,04 g Carboxymethylcellulose 0,1 g p-Hydroxybenzoesäuremethylester 0,05 g p-Hydroxybenzoesäurepropylester 0,01 g Rohrzucker 10,0 g Glycerin 5,0 g Sorbitlösung 70 % 20,0 g Aroma 0,3 g Wasser dest. ad 100,0 ml Herstellungsverfahren: Dest. Wasser wird auf 700C erhitzt. Hierin wird unter Rühren p-Hydroxybenzoesäuremethylester und -propylester sowie Glycerin und Carboxymethylcellulose gelöst. Es wird auf Raumtemperatur abgekühlt und unter Rühren der Wirkstoff zugegeben und homogen dispergiert. Nach Zugabe und Lösen des Zuckers, der Sorbitlösung und des Aromas wird die Suspension zur Entlüftung unter Rühren evakuiert. Suppository weight: 1.7 g Example D suspension with 2 mg of 8-benzylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimido / 3,4-d7-pyrimidine 100 ml suspension contain: active substance 0.04 g carboxymethyl cellulose 0.1 g p-hydroxybenzoic acid methyl ester 0.05 g propyl p-hydroxybenzoate 0.01 g cane sugar 10.0 g glycerin 5.0 g sorbitol solution 70% 20.0 g aroma 0.3 g distilled water. ad 100.0 ml Manufacturing process: distilled water is heated to 700C. P-hydroxybenzoic acid methyl ester is added with stirring and propyl esters as well as glycerine and carboxymethyl cellulose dissolved. It gets to room temperature cooled and the active ingredient added with stirring and homogeneously dispersed. To Adding and dissolving the sugar, the sorbitol solution and the flavor becomes the suspension evacuated with stirring for venting.
Beispiel E Ampullen mit 1 mg 8-Benzylamino-4-(1-oxido-thiomorpholino)-2-piperazino-pyrimidot5 , 4-pvrimidin 1 Ampulle enthält: Wirksubstanz 1,0 mg Essigsäure 0,01 N 0,3 ml NaCl 18,0 mg Wasser für Injektionszwecke ad 2,0 ml Herstellung: In einem geeichten Ansatzgefäß wird die Wirkstoffbase in Wasser für Injektionszwecke suspendiert und unter Erwärmen und Zutropfen von Essigsäure vollständig gelöst. Nach Filtration über Membranfilter wird die Lösung in Ampullen abgefüllt und autoklaviert.Example E Ampoules containing 1 mg of 8-benzylamino-4- (1-oxido-thiomorpholino) -2-piperazino-pyrimidote 5 , 4-pvrimidin 1 ampoule contains: active substance 1.0 mg acetic acid 0.01 N 0.3 ml NaCl 18.0 mg water for injections to 2.0 ml Production: in one In a calibrated preparation vessel, the active ingredient base is suspended in water for injection purposes and completely dissolved by heating and dropping acetic acid. After filtration The solution is filled into ampoules through a membrane filter and autoclaved.
Claims (1)
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803013930 DE3013930A1 (en) | 1980-04-11 | 1980-04-11 | 2-Per:hydro:diazine-pyrimido-pyrimidine derivs. - with antithrombotic activity, used e.g for prophylaxis of thromboembolic and arteriosclerosis |
| AT80103408T ATE9471T1 (en) | 1979-07-03 | 1980-06-19 | 2-(PERHYDRO-1,4-DIAZINO)-PYRIMIDO(5,4D)PYRIMIDINE, THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS. |
| DE8080103408T DE3069211D1 (en) | 1979-07-03 | 1980-06-19 | 2-(perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them |
| EP80103408A EP0023559B1 (en) | 1979-07-03 | 1980-06-19 | 2-(perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them |
| IE1354/80A IE50139B1 (en) | 1979-07-03 | 1980-06-30 | 1,2-(perhydro-1,4-diazino)-pyrimido 5,4-d pyridines and pharmaceutical compositions containing them |
| PT71478A PT71478B (en) | 1979-07-03 | 1980-07-01 | NEW 2- (PERHYDRO-1,4-DIAZINO) -PYRIMIDO <5,4-D> PYRIMIDINE THEIR PREPARATION AND THE MEDICAMENTS CONTAINING THEREOF |
| FI802102A FI67220C (en) | 1979-07-03 | 1980-07-01 | FRUIT PROTECTION OF ANTITROMBOTIC VERKANDE 2-PERHYDRO-1,4-DIAZINO) -PYRIMIDO (5,4-D) PYRIMIDINER |
| IL60454A IL60454A (en) | 1979-07-03 | 1980-07-01 | Trisubstituted pyrimidopyrimidine derivatives,their preparation and pharmaceutical compositions containing them |
| DK284280A DK153487C (en) | 1979-07-03 | 1980-07-01 | ANALOGY PROCEDURE FOR PREPARING 2- (PERHYDRO-1,4-DIAZINO) -PYRIMIDOOE5,4-DAAPYRIMIDINE DERIVATIVES |
| CA000355257A CA1145746A (en) | 1979-07-03 | 1980-07-02 | 2-(perhydro-1,4-diazino)-pyrimido[5,4-d] pyrimidines, their preparation and pharmaceutical compositions containing them |
| NO801989A NO152843C (en) | 1979-07-03 | 1980-07-02 | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIMIDOPYRIMIDINES. |
| ES493016A ES493016A0 (en) | 1979-07-03 | 1980-07-02 | PROCEDURE FOR THE PREPARATION OF NEW 2- (PERHI-DRO-1,4-DIAZINO) -PIRIMIDO (5,4-D) PIRIMIDINAS |
| AU60044/80A AU541307B2 (en) | 1979-07-03 | 1980-07-02 | Pyrimido (5,4-d) pyrimidine derivatives |
| GR62352A GR69326B (en) | 1979-07-03 | 1980-07-03 | |
| NZ194228A NZ194228A (en) | 1979-07-03 | 1980-07-03 | 2-(1,4-diazacycloalk-1-yl)-4-(morpholino or thiomorpholino)-8-substituted pyrimido(4,5-b)pyrimidines |
| PH29576A PH25388A (en) | 1979-07-03 | 1983-09-22 | 2-(PERHYDRO-1,4-DIAZINO)-PYRIMIDO-£5,4-d|-PYRIMIDINES, SALTS THEREOF |
| US06/575,333 US4518596A (en) | 1979-07-03 | 1984-01-31 | Antithrombotic use of 2-(perhydro-1,4-diazino)-pyrimido (5,4,D)-pyrimidines |
| US06/712,341 US4690923A (en) | 1979-07-03 | 1985-03-15 | 2-(Perhydro-1,4-diazino)-pyrimido(5,4-D)-pyrimidines, pharmaceutical compositions and use |
| US07/007,990 US4728646A (en) | 1979-07-03 | 1987-01-28 | 2-(perhydro-1,4-diazino)-pyrimido[5,4-d]-pyrimidines and salts thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803013930 DE3013930A1 (en) | 1980-04-11 | 1980-04-11 | 2-Per:hydro:diazine-pyrimido-pyrimidine derivs. - with antithrombotic activity, used e.g for prophylaxis of thromboembolic and arteriosclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3013930A1 true DE3013930A1 (en) | 1981-10-22 |
Family
ID=6099750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19803013930 Ceased DE3013930A1 (en) | 1979-07-03 | 1980-04-11 | 2-Per:hydro:diazine-pyrimido-pyrimidine derivs. - with antithrombotic activity, used e.g for prophylaxis of thromboembolic and arteriosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE3013930A1 (en) |
-
1980
- 1980-04-11 DE DE19803013930 patent/DE3013930A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004010848T2 (en) | DERIVATIVES OF 1-PIPERAZINE AND 1-HOMOPIPERAZINE CARBOXYLATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS INHIBITORS OF THE FAAH ENZYME | |
| DE2614406C2 (en) | ||
| US3812127A (en) | 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters | |
| DE3036390A1 (en) | Antiinflammatory intermediate 7H-pyrrolo-(2,3-D)-pyrimidine derivs. - prepd. by dealkylation of 7-phenyl:ethyl derivs. by reaction with hydrochloric, phosphoric or poly:phosphoric acid | |
| DD211555A5 (en) | PROCESS FOR PREPARING NEW 4-AMINO-6,7-DIMETHOXYCHINOLINE DERIVATIVES | |
| DE2720085C2 (en) | ||
| CH642078A5 (en) | PYRIDOPYRIMIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. | |
| EP0387821B1 (en) | 2-Alkyl-4-arylmethylaminoquinolines, their use and medicines containing them | |
| DE2849537A1 (en) | SUBSTITUTED 5- (2-IMIDAZOLIN-2-YL) AMINOPYRIMIDINE AND METHOD FOR PRODUCING THE SAME | |
| DE4228095A1 (en) | New 4,5-dihydro-4-oxopyrrolo [1,2-a] quinoxalines and corresponding aza analogues and processes for their preparation | |
| DE2424334A1 (en) | PROCESS FOR PRODUCING NEW HETEROCYCLIC COMPOUNDS | |
| DE69106902T2 (en) | Imidazopyridazines, their production and use. | |
| US3806509A (en) | 6-acylaminophenyl-4,5-dihydropyridazones | |
| DE3049207A1 (en) | NEW TRISUBSTITUTED PYRIMIDO (5,4-D) PYRIMIDINE, THEIR PRODUCTION AND USE AS A MEDICINAL PRODUCT | |
| DE19629378A1 (en) | New triazolopurines, process for their preparation and their use as medicaments | |
| US4129738A (en) | 5-Phenylpyrazolo[1,5-a]pyrimidin-7(1H)-ones | |
| EP0023559B1 (en) | 2-(perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them | |
| DE3013930A1 (en) | 2-Per:hydro:diazine-pyrimido-pyrimidine derivs. - with antithrombotic activity, used e.g for prophylaxis of thromboembolic and arteriosclerosis | |
| IE912261A1 (en) | New oxazolopyridine compounds, process for preparing these¹and pharmaceutical compositons containing them | |
| US3024243A (en) | New derivatives of pyrrolopyridines and pyrroloquinolines and methods of preparing the same | |
| US4260612A (en) | Antiallergic nitrogen bridge-head compounds | |
| Kökösi et al. | Nitrogen bridgehead compounds. Part 19. Synthesis of polymethylenepyrimidin‐4‐ones | |
| JPS5825678B2 (en) | Oxazole powder | |
| US2934535A (en) | Z-amino-x-trifluoromethylanilino-s | |
| DE1904081A1 (en) | Benzoxazine Derivatives and Processes? Manufacturing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8131 | Rejection |